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Abstract 
 
Enzyme promiscuity, defined as functional properties other than those for which they are 
evolved, is considered a key factor in the evolution of new enzyme functions. Many 
metalloproteins can be alternatively metallated, which may lead to metal-dependent 
promiscuity. The mechanisms and evolutionary implications of metal-mediated promiscuity 
appear to be underexplored, especially considering that approximately one-third of 
structurally characterized proteins are thought to be metalloproteins. 
 
Here, we investigated the bacterial binuclear metallohydrolase, N-Succinyl-L-L-
Diaminopimelic acid desuccinylase DapE (EC 3.5.1.18) of S.enterica. DapE is an essential 
enzyme in the late stage of the lysine biosynthetic pathway that also provides a crucial 
building block of the peptidoglycan cell wall. Since DapE is essential for most Gram-negative 
and many Gram-positive bacteria and it is not present in humans, it has been proposed as a 
very good target for antibiotic development. It was also reported that DapE has a metal 
dependent promiscuous aspartyl dipeptidase activity, in which incorporation of either zinc or 
manganese to the enzyme leads to activity with different substrates and this phenomenon 
occurs both in vivo and in vitro. 
 
We addressed the reaction mechanism of the native desuccinylase activity as well as the 
Mn2+-dependent aspartyl dipeptidase promiscuous activity of DapE, by investigating a series 
of substrate analogues and potential inhibitors. We postulated a plausible mechanism for 
metal-dependent promiscuity, based on subtle differences in coordination preferences 
between Mn2+ and Zn2+,which may be widely applicable to other enzymes. We revealed why 
a promising inhibitor of the enzyme in vitro, L-captopril, fails to exert antibiotic activity and 
propose broad practical implications of this discovery for drug-design, as well as fundamental 
evolutionary implications. We described kinetic cooperativity in DapE, which offers clues on 
structural rearrangements that occur during catalysis and is also of relevance to inhibitor 
design.  
 
Finally, we explored the evolutionary aspects of functional robustness of native activity over 
the promiscuous activity using DapE as a model enzyme and addressed the molecular 
mechanisms underlying the emergence of functional robustness through laboratory evolution.  
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CHAPTER 1 
 
Introduction 
 
Approximately one-third of structurally characterized proteins and approximately half of all 
proteins are thought to be metalloproteins.1-5 All living organisms require a variety of 
different metals, each of which has a rich and unique chemistry that is exploited to confer 
specific structural, regulatory and catalytic properties to proteins. 
 
Selective metal utilization suggests that it is crucially important to incorporate the right metal 
for the right task and that this is a process that has been tailored carefully by evolution. For 
example, redox-inert metal ions like Zn2+ are often used in enzymes to stabilize negative 
charges and to activate substrates by virtue of their Lewis acid properties. In contrast Cu2+, 
which is also a strong Lewis acid, is seldom used in Nature as such, perhaps because the 
stability of Cu2+–ligand bonds can make it a relatively inefficient Lewis-catalyst; instead, 
copper is used in natural enzymes mostly for its redox-activity.6 
 
Cells use both thermodynamic and kinetic mechanisms to incorporate the right metal into 
metalloproteins. The elucidation of these intricate control mechanisms remains a question of 
great fundamental interest.7 However, biology is notoriously messy 8 and the “correct metals” 
may not always be incorporated into proteins. 
 
Enzyme promiscuity 
 
What are the consequences of a “wrong” metal being incorporated into a protein? Here we 
argue that such metal-substitution can lead to very different outcomes: metallation can be a 
source of toxicity and metabolic disruption, but also a source of phenotypic diversity, thus 
conferring potential evolutionary innovation through metal-mediated promiscuity. 
 
Enzyme promiscuity has been defined by Khersonsky and Tawfik as the occurrence of 
enzyme activities other than those for which an enzyme evolved and that are not part of the 
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organism’s physiology.9 We aim to understand in detail the particular case of changes in 
enzyme specificity arising from metal-substitution, i.e. metal-mediated enzyme promiscuity. 
 
Thermodynamic mechanisms 
• Type, number and orientation of ligands: 
 
a) Ligand preference of metals, e.g. Irving-
Williams series 10 
 
b) Metal-preference of coordination geometry 
 
Environmental factors 
• Type of medium for the cell growth 
• Location of enzyme activity in the cells 
• Global availability of metals 
• Bio-availability of the metals  
• pH 
• Redox status 
Kinetic mechanisms 
• Location of the protein folding in the cells 
• Effect of metallo chaperones 
Genetic variations 
• Point mutations 
• Enzyme isoforms 
• Species variations 11 
Table 1: Factors that influence metal promiscuity 
 
The adequate incorporation of metals into proteins takes advantage of both thermodynamic 
and kinetic control-mechanisms.12-16 Thermodynamic mechanisms depend on metal 
availability in the protein environment and the intrinsic properties of metals. A common 
example of metal properties is reflected in the well-known Irving-Williams series of first-row 
divalent transition metals.10 This series states that, in general, at equal concentrations of metal 
ions, the binding of Zn and Cu to protein ligands prevail over Mn-binding. However, such 
general thermodynamic preferences can be modulated in many additional subtle ways, for 
example by adapting the type, number and orientation of the ligands to suit the soft/hardness 
of the target metal and its preferred coordination geometry.17 On the other hand, kinetic 
factors can dominate the distribution of metals in cells. In vivo, for example, the location of 
protein-folding may determine metallation and metallo-chaperones may also help to deliver 
metals to specific targets (Table 1). 
 
Metallation of proteins in vivo 
 
Exact knowledge of the metallation state of proteins in vivo is often thwarted with 
experimental difficulties.5,18,19 Moreover, because metallation of proteins arises from complex 
interactions between thermodynamic and kinetic interactions (Table 1), the metal species 
bound to a protein may exhibit strong dependence on cell-context, differing for example in 
different media, cell-locations or in different species.7 Such a cell-context dependence is 
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acutely illustrated by manganese superoxide dismutase (Mn-SOD) of E.coli,20 an enzyme that 
requires Mn (not Fe) for activity. When this enzyme was over-expressed recombinantly in 
E.coli grown in medium supplemented with ferrous salts, Fe substituted for Mn in the active 
site.21 The X-ray structure of this Fe-isozyme revealed a substrate-access channel blocked by 
solvent (either water or hydroxide), which provides a plausible explanation for lack of 
catalytic activity in the wrongly-metallated form.22 Conversely, the incorporation of a metal 
that is not thought to be physiological may also lead to increased activity: a classical example 
of such enzyme activation is the metallation of Aeromonas leucine aminopeptidase with 
copper instead of zinc.23 These studies show that one should be very cautious of concluding 
the nature of the physiologically-relevant metal based on enzyme activation alone. 
 
Cambialistic enzymes: superoxide dismutases 
 
The low metal-selectivity of proteins, which leads to alternatively metallated forms with 
differing activities according to the cellular environment, has been referred to as “metal 
promiscuity”.16 A more common term found in the literature on metalloproteins is 
“cambialism”, which mostly refers to enzymes that are active with different metals. For 
example, there are a few “cambialistic superoxide dismutases” that retain measurable activity 
with various metals,24,25 typically shown for Fe and Mn. In the case of many metalloproteins 
with cambialistic behaviour, the most physiologically relevant metallo-isoform may be 
difficult to establish and it may be that both (Fe & Mn) are used by the organism according to 
environmental availability, which may be dependent on the redox state of the cell. Under 
more oxidative conditions there may be a lowered availability of Fe due to formation of the 
less soluble Fe(III) species and therefore the Mn isoform of SOD may predominate. 
 
Therefore, change in metallation may be environmentally-controlled in a physiologically-
relevant manner without invoking genetic change. However, cambialism may be a careful 
balance between genetic and environmental factors. 
 
Curiously, in E.coli Mn-SOD, there are mutations in the second-coordination sphere that 
modulate metal-selectivity, such as Glu170Ala. This genetic variant lacks an outer-sphere 
cross-link between active-sites in adjacent subunits and was isolated as an Fe-isoform even 
upon Mn-supplementation of bacterial cultures.26 
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Similarly, a mutation ~10Å away from the active site, Gly155Thr in the SOD from 
P.gingivalis, changed the activity ratio of Fe vs Mn from 0.6 in the wild type to 11.2 in the 
mutant.27 Remarkably, such change of metal-specificity was accompanied by a doubling of 
the specific activity of the Fe-enzyme in vitro compared with the wild type, suggesting an 
evolutionary adaptation for properties other than maximal activity and, we speculate, the 
possibility of an evolutionary advantage for low metal-selectivity. Trade-offs, such as sub-
optimal activation in exchange for adaptability to metal-availability, may be common in 
biology.28 
 
Cambialism in evolution: a cadmium-containing carbonic anhydrase 
 
The term “cambialism” has also been used in the context of putative changes in metal-
cofactor usage by enzymes through evolution, for example due to changing environmental 
metal-availability, such as is thought to have occurred with availability of Fe upon advent of 
photosynthesis and the resulting change to a more oxidative atmosphere.29 An example of 
such cambialism in evolution is the apparent adaptation of a carbonic anhydrase from marine 
diatoms to the scarcity of Zn in their environment: this enzyme was shown to exchange 
readily cadmium and zinc at its active site, a property that may provide a selective advantage 
to the organism when competing for metal-availability, particularly because Zn is scarce in its 
environment.30 There has been an intense discussion on whether Zn-containing 
metalloenzymes may have been most abundant at the dawn of life.31,32 Considering that Fe 
may have been much more abundant, together with the biochemical possibility of cambialism 
between Fe2+ and Zn2+, we suggest that it is very plausible that some metalloenzymes that 
require Zn2+ today may have been evolved from enzymes that were mostly Fe2+-containing in 
the past. 
 
Metal-mediated substrate promiscuity in vitro 
 
Enzymatic characterization of metalloproteins in vitro may lead to a change in substrate-
selectivity according metal-supplementation. An example of such metal-mediated substrate 
promiscuity is the L-carbamoyl amino acid hydrolase from Geobacillus stearothermophilus 
CECT43.33 Mn2+ activation of the metalloenzyme gave similar levels of hydrolysis for N-L-
acetyl methione and N-L-carbamoyl methione substrates. However, when activated with Ni2+, 
this promiscuous hydrolase exhibited a doubling of activity for N-L-acetyl methione. 
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Remarkably, this doubling of activity was substrate-specific, because the Ni2+ enzyme 
retained comparable levels of hydrolysis for N-L-carbamoyl methione as found for the Mn2+ 
isoform. Only the Ni2+ isoform, therefore, had a preference for the acetylated substrate 
compared with the methylated substrate. 
 
Metal substitution may also lead to activity with new substrates. Cappielo et al. reported that 
the Mn/Zn isoform of the binuclear leucyl aminopeptidase from bovine lens generated a novel 
activity toward Cys-Gly, a substrate which is not hydrolysed by the Zn/Zn enzyme.34,35 
Although the Cys-Gly substrate was not hydrolysed by the Zn/Zn isoform, this compound was 
a competitive inhibitor for the more physiologically relevant Leu-Gly substrate, with a Ki 
value of 16.4 µM. Resolution of the crystal structure of the Zn/Zn isoform bound to the 
sulfhydryl-drug Zofenoprilat, together with modeling studies, provided a plausible 
explanation for such substrate-selectivity: the presence of the S atom at the Zn2+ coordination 
site 1, displaced the water molecule fundamental for catalysis and did not allow a Cys-Gly 
orientation within the enzyme active site that is productive for dipeptide hydrolysis. In 
contrast, it was surmised that a Mn2+ ion in site 1, an ion that prefers oxygen or nitrogen-
containing ligands, allowed a productive orientation of the sulfur containing compounds, thus 
making them good substrates. 
 
A cancer-associated protein phosphatase 2C was also shown to exhibit metal-mediated 
substrate selectivity in vitro.36 The Mn2+ ion was most effective in activating the enzyme for 
dephosphorylation of the artificial substrate para-nitrophenyl phosphate (pNPP). For 
comparison, in this assay the Mg2+-enzyme exhibited about 7-fold less activity than the Mn2+ 
enzyme. Surprisingly, Mg2+ was clearly a much better cofactor (leading to about 7-fold more 
activity than Mn2+) when using the protein casein as substrate. Other distantly related type 2C 
phosphatases from bacteria also showed substrate preferences according to metallation either 
with Mn2+ or Mg+. For example, the PrpZ phosphatase from Salmonella enterica was shown 
to exhibit a strong preference for Mn2+ when assaying dephosphorylation of pNPP in vitro. 
However, the Mn2+ metalloenzyme was only two-fold more effective than the Mg2+isoform 
when using myelin basic protein as a substrate.37 Similarly, the Stp1 phosphatase from 
Bacillus anthracis clearly exhibited higher activity for pNPP with Mn2+, rather than Mg2+, 
which worked less effectively for hydrolysis.38 The same preference for Mn2+ was found 
when using the phosphopeptide RRA(pS)VA as substrate. Remarkably, there was no such 
clear preference for either metal when using the closely related phosphopeptide RRA(pT)VA 
	
   6	
  
as substrate. Cumulatively, these biochemical data measured in vitro suggest that Mn2+/Mg2+-
mediated substrate promiscuity may be common in type 2C phosphatases, even in distantly-
related species. Moreover, although the concentrations of metals used in these studies were 
rather high (Mn2+ often between 1 and 10 mM), these findings suggest the possibility that the 
ratio of the available pool of Mn2+ and Mg2+ present intracellularly could be used as a 
mechanism to regulate the preferred substrates of these enzymes in vivo. 
 
Metal-mediated substrate promiscuity in vivo 
 
The relevance of the novel activities of the different metallated forms of enzymes such as 
leucyl aminopeptidase or phosphatases 2C in vivo is unclear, because these enzymes were 
expressed in recombinant form and characterized in vitro. However, there is increasingly 
compelling evidence that mixed-metallation can occur in some cases in vivo, which may be 
relevant for activity. For example, the Mn/Zn homologous enzyme from Pseudomonas putida 
was shown to be more active than the Zn/Zn isoform when using L-phenylglycine amide as a 
substrate. This activity assay was used to show that recombinantly expressed in E.coli 
contained Mn in site 1, even though Zn was thought to be the preferred metal and despite that 
neither the medium nor any of the buffers used in the purification procedure had been 
supplemented with Mn.39 An even more illustrative example is given by the dapE-encoded N-
succinyl-L,L-diaminopimelic acid desuccinylase (DapE), which cleaves the N-succinyl-L,L-
diaminopimelic acid (SDAP) to form L,L-diaminopimelic (L,L-DAP) acid and succinate.40 
This binuclear metalloenzyme is thought to contain co-catalytic Zn ions in its active site in 
physiological conditions. However, DapE presents also a promiscuous dipeptidase activity.41 
In the presence of manganese ion (Mn2+), one of the Zn2+ is exchanged by Mn2+, which allows 
DapE to cleave aspartyl dipeptides in vitro.41 In contrast, the Zn2+ enzyme, whether 
mononuclear or binuclear, is totally inactive for the promiscuous aspartyl-hydrolase activity. 
Importantly, enzyme promiscuity was also suggested to occur in vivo. In a series of elegant 
experiments using a bacterial strain deficient for all other aspartyl-dipeptidases and also 
unable to synthesize leucine, Broder & Miller showed that the growth of the bacteria on 
medium containing only the dipeptide Asp-Leu as a leucine source was strictly dependent on 
DapE expression.41 The observation of such DapE-dependent growth led to the inescapable 
conclusion that sufficient Mn must be present inside the cell to lead to DapE promiscuous 
activity, even in minimal medium without any additional metal supplementation.CLES 
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R. KpnI is a Type II restriction enzyme, cleaving double-stranded DNA in the presence of 
many metal cations. It is the nature and concentration of the cation leads to various degrees of 
activity and fidelity of substrate recognition. Ca2+ and Zn2+ both induce robust and specific 
hydrolytic activity. However, it is a highly promiscuous enzyme in Mg2+- and particularly in 
Mn2+ catalyzed reactions. It was speculated that the flexibility in metal ion utilization by 
R.KpnI could provide the organism with an evolutionary advantage since the restriction 
enzyme could function regardless of the availability of a particular metal ion.42 Moreover, 
considering that the free intracellular concentrations of Mg2+ range from 0.3 to 2 mM, it is 
feasible that facile exchange with Mg2+ is an evolved mechanism to modulate the degree of 
promiscuity in vivo. Clearly, the biological relevance of the promiscuous DNA cleavage is an 
important question that needs further investigation. 
 
Metal-mediated promiscuous reaction mechanisms. 
 
In some cases, the nature of the metal in an enzyme active site appears to select not only the 
substrate, but also determined the type of chemical transformation that takes place. The non-
heme Fe2+-dependent dioxygenase Dke1 from Acinetobacter johnsonii converts 2,4-
pentanedione and O2 into methyglyoxal and acetate. The Fe is coordinated by the triad His62, 
His64, and His104 (Figure 1) and is absolutely required for oxygenase activity, since other 
metal ions, like Zn2+, Ni2+ or Cu2+, that compete with Fe2+ for binding are completely inactive 
in the enzymatic reaction with O2. However, the enzyme is catalytically promiscuous as a 
metallohydrolase, cleaving 4-nitrophenylesters either in the Fe or Zn mononuclear isoform. 
The non-native Zn2+ form of the enzyme is the more active esterase, exhibiting about ten-
times more activity than the Fe2+ enzyme. Most remarkably, substitution of His104 by Glu 
(Figure 1), which destroys the oxygenase activity, is compatible with the function as a 
Fe2+/Zn2+ esterase, exhibiting more than 10% remaining catalytic proficiency (kcat/KM). 
Analysis of the reported kinetic data reveals metal-dependent substrate promiscuity, since the 
ratio of the second-order rate constant (kcat/KM) for pNPP between the Zn and Fe isoform is 
approximately half of that of pNPB hydrolysis between the Zn and Fe isoforms.43	
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Figure 1. Active site of oxygenase Dke1 wild type (A) and modelled mutant H104E (B). The mutation 
destroys the Fe2+-dependent oxygenase activity but is compatible with the promiscuous function as a 
Fe2+ or Zn2+ esterase, exhibiting more than 10% remaining catalytic proficiency (kcat/KM). Image 
created from Pymol using PDB: 3BAL file of wild type Dke1. 
 
Conversely, the purple acid phosphatases (PAPs) are thought to be physiological hydrolases, 
some of which may exhibit promiscuous oxidase activity. These binuclear enzymes are found 
throughout all kingdoms of life and their colourful name originates from the chromophore 
generated by a charge-transfer between a tyrosinate and Fe3+ ion within the binuclear metal 
center.44-47 The catalytic center and active-site domain are largely conserved despite the very 
low sequence similarity amongst different enzyme orthologs. Importantly, the nature of the 
second metal, a catalytically-important divalent cation in all cases, varies amongst the first-
row transition metals: Fe2+, Zn2+ and Mn2+. It is notable that plants in particular have an 
abundance of PAPs with many different metallo-isoforms. As well as their well-characterised 
phosphatase activity, several PAPs have been reported to exhibit radical-forming activity, 
which requires a redox-active second metal, such as Fe in the case of human PAP.48 Over 
expression of PAP increases oxygen-and nitrogen radical generation in vivo and increases the 
bactericidal activity of macrophages 49 and this radical-forming activity has been reported to 
be controlled independently of its phosphatase activity.50 Moreover, preparations  of a 
mammalian PAP, normally thought to be a mixed binuclear Fe3+-Fe2+ active species have 
been isolated from bovine spleen containing trace amounts of a “contaminant” corresponding 
to a non-redox active Fe3+-Zn2+ species, which is presumably incompetent for catalyzing 
production of oxygen and nitrogen radicals.51 As an aside, it is noteworthy that the Fe3+ metal 
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in PAP has been substituted for an Al3+ ion to form a colourless enzyme species, which 
remains, however, catalytically active as a phosphatase. Although this Al-containing species 
is unlikely to be biologically-relevant, it remains to our knowledge the only example of a 
catalytically-active aluminium enzyme species.52 
 
Metal-mediated moonlighting function 
 
The significance of the various metallated forms of PAP in vivo, conferring different catalytic 
and regulatory properties remains speculative. Thus, it is unclear whether the di-iron and 
other redox-active isoforms truly have dual activities in vivo that may have been selected in 
evolution: if such is indeed the case rather than speaking of a promiscuous function, which by 
definition has not been selected in evolution, one could refer to such dual-enzymes as 
“moonlighting proteins”.53 “Moonlighting” has been defined as “the utilization of protein 
parts outside the active site for other functions, mostly regulatory and structural”.9 The 
regulation of such putative metal-mediated moonlighting proteins would be a worthwhile 
topic for exploration. For example, it would be interesting to investigate whether any of the 
PAPs are metallated differently in alternative compartments, with the metal used varying 
according to the required function. An example of “moonlighting protein” that is worthy of 
mention is the Iron-Regulated Protein 1 (IRP1), which alternates between an active cytosolic 
aconitase form that has an iron-sulfur cluster ligated to its active site and an apoprotein form 
that regulates iron homeostasis. 54 Thus, the apoprotein appears to contribute to the regulation 
of its own conversion to an enzymatically active metalloprotein: this regulation is achieved by 
binding to iron response elements (IREs) in the mRNA of ferritin, an important iron-storage 
protein. 
 
Metallation of proteins in vitro for the creation of artificial metalloenzymes. 
 
Metal-mediated enzyme promiscuity is very relevant for the expanding field of protein design 
and evolution, because this phenomenon can be exploited for the creation of new activities in 
the laboratory. We have shown several examples above, where the nature of the metal in the 
active site influences the chemical transformation. Already in the 1970’s, Emil Kaiser and 
colleagues recognized that metal-ion substitution in metalloenzymes in vitro could yield novel 
activities that could act on biologically important substrates.55,56 This postulate was 
demonstrated elegantly by preparing the Cu2+ form of carboxypeptidase A, which abolished 
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the hydrolytic activity of the enzyme but conferred oxidative activity on ascorbic acid to 
produce dehydroascorbic acid in vitro. More recently, a di-Cu+ substituted aminopeptidase 
was shown to acquire catechol oxidase activity.57 Metal exchange of carbonic anhydrase II in 
vitro has been used successfully for the creation of a series of catalysts, including for 
epoxidation,58 peroxidation59 and hydroformylation.60 In addition, effective sulphoxidation 
catalysts were achieved by substitution of the Zn2+ in thermolysin with tungstate.61 As an 
aside, it has also been shown that direct coordination of metals into proteins that are not 
normally metal-binding can also give rise to nascent enzymatic activities in vitro, for example 
in enantioselective vanadium-mediated sulphoxidation62 and osmium-mediated 
dihydroxylation63 using the non-enzymatic protein scaffolds. There are also numerous 
examples of semi-synthetic metalloenzymes, constructed either by replacing a metal in a 
natural organic co-factor or by attaching a synthetic metal-ligand to a biomolecule.64-67 It 
should be noted that in many cases the metals used for such catalysis in vitro, including noble 
metals like rhodium, are non-physiological and with no known biological relevance; 
nevertheless, these more exotic metals have attractive chemical properties that can be 
exploited for the design of artificial metalloenzymes. 
 
In summary, control and prediction of metallation in proteins is thwarted with experimental 
difficulties and its effects on catalysis are often surprising and unpredictable.5,18,19 Non-strict 
metal incorporation can be used as a facile way to create catalytic diversity 68 and, indeed, 
may be common in proteins and exploited as an evolutionary mechanism to generate 
phenotypic diversity. Finally, in a biomimetic spirit, such metal-mediated promiscuity may be 
exploited in vitro, for example in the context of biocatalysis. 
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 Enzyme Metal Enzyme Activity Ref. 
 
1 E.coli Mn-SOD, Wt Mn2+ Active 69 
  Fe2+ Inactive 21	
  
 
 E.coli Mn-SOD, E170A Fe2+ Active 26	
  
 
2 Aeromonas Leucine Zn2+ Active 23 
 Aminopeptidase Cu2+ More active than Zn2+  
 
3 SOD Fe2+ Active 24 
  Mn2+ Active  
 
4 P.gingivalis SOD, Wt Fe2+ 1600 27 
  Mn2+ 2700 more than Fe2+  
 
 P.gingivalis SOD, G155T Fe2+ 2-fold more than wild type  
  Mn2+ 9-fold less than wild type  
 
5 Carbonic anhydrase Zn2+ Active 30 
  Cd2+ Active  
 
   N-L-acetyl methione   
6 L-carbamoyl Mn2+ Active 33 
 aminoacid hydrolase Ni2+ 2-fold more than Mn2+  
   N-L-carbamoyl methione   
  Mn2+ Active  
  Ni2+ Active  
     
7 Bovine lens 
leucyl aminopeptidase 
Zn12+/Mn22+ Active 34,35 
  Zn12+/Zn22+ Inactive  
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   Oxygenase activity 70 
8 Dioxygenase Dke1, Wt Fe2+ Active  
  Zn2+, Ni2+ 
or Cu2+ 
Inactive  
 
 
 Dioxygenase Dke1, H104E Fe2+ Inactive  
 
   Esterase activity  
 Dioxygenase Dke1, H104E Fe2+ Active as wild type  
  Zn2+ 10-fold more active than Fe2+  
 
   pNPP as substrate  
9 2C Protein phosphatase Mn2+ Active 71 
  Mg2+ 7-fold more than Mn2+  
 
   Protein Casein as substrate  
  Mn2+ Active  
  Mg2+ 7-fold increase than Mn2+  
 
   SDAP as substrate  
10 DapE Zn12+/-- Active (Less active) 72 
  Zn12+/Zn22+ More active than mono-Zn2+ 72 
  Zn12+/Mn22+ More active than di-Zn2+ This 
work 
 
   Asp-Leu as substrate 41 
  Zn12+/-- Inactive  
  Zn12+/Zn22+ Inactive  
  Zn12+/Mn22+ Similar to SDAP activity  
 
Table 2. List of Metal-dependent Promiscuous enzymes discussed in this report. Wt is wild type. DapE 
is N-Succinyl-L-L-Diaminopimelic acid desuccinylase. SDAP is Succinyl Diaminipimelic acid. pNPP is 
para-Nitrophenyl Phosphate. SOD is Superoxide dismutase. 
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CHAPTER 2 
 
Selectivity of inhibition of N-succinyl-L,L-diaminopimelic acid 
desuccinylase (DapE) in bacteria:  
DapE is not the target of L-captopril antimicrobial activity. 1 
 
Abstract 
 
The emergence of bacterial strains that are resistant to virtually all currently available 
antibiotics underscores the importance of developing new antimicrobial compounds.2,3 N-
succinyl-L,L-diaminopimelic acid desuccinylase (DapE) is a metallohydrolase involved in the 
meso-diaminopimelate (mDAP)/lysine biosynthetic pathway necessary for lysine biosynthesis 
and for building the peptidoglycan cell wall.4 Because DapE is essential for Gram-negative 
and some Gram-positive bacteria, DapE has been proposed as a good target for antibiotic 
development.5 Recently, L-captopril has been suggested as a lead compound  for inhibition of 
DapE, although its selectivity for this enzyme target in bacteria remains unclear.5 Here, we 
tested the selectivity of L-captopril against DapE in bacteria. Since DapE knockout strains of 
gram-negative bacteria are viable upon chemical supplementation with mDAP, we reasoned 
that the antimicrobial activity of compounds targeting DapE should be abolished in mDAP-
containing media. To our surprise, although we confirmed that L-captopril has modest 
antimicrobial activity in bacteria, the inhibition of bacterial growth was independent both of 
mDAP supplementation and DapE over-expression, in Escherichia coli and in Salmonella 
enterica. We conclude that DapE is not the main target of L-captopril inhibition in these 
bacteria. The methods implemented here will be useful for screening for DapE-selective 
antimicrobial compounds directly in bacterial cultures. 
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Introduction 
 
Most novel antibiotics that are developed are simply broad-spectrum, structural variants of a 
limited set of known of bioactive compounds, many targeting the same enzymatic pathways. 
Consequently, the risk that pathogenic bacterial strains eventually evolve resistance against 
new antibiotics is very high.2,3 To help combat the serious problem of antibiotic resistance, it 
is imperative that new enzymatic targets are identified and that their specific inhibitors are 
developed. DapE, N-succinyl-L,L-diaminopimelic acid desuccinylase of the meso-
diaminopimelate (mDAP)/lysine biosynthetic pathway of bacteria has been identified as an 
attractive potential antibiotic target.6 DapE is a terminal enzyme for the hydrolysis of the N-
succinyl-L,L-diaminopimelic acid (SDAP) (Scheme 1) into succinate and DAP.7 Two of the 
products of this pathway (mDAP and lysine) are essential components of the cell: lysine is a 
protein-amino acid and DAP is a necessary component of the peptidoglycan cell wall of all 
Gram-negative and many Gram-positive bacteria.4,6 Since there is no enzyme in mammals 
similar to DapE, the inhibitors of DapE could potentially provide selective toxicity against 
bacteria and have little or no effect on humans.  
 
DapE is a homo-dimeric enzyme, with each monomer (41.6 KDa) containing two structural 
domains: a dimerization domain and a catalytic domain with a di-zinc active site.7,8 Sequence 
alignment of all known DapE enzymes, including of E.coli and S.enterica, with the 
structurally characterized DapE of H.influenzae and Neisseria meningitides, point toward the 
very strict conservation of all the amino acids that function as metal ligands and putative 
substrate binding sites.7,9-11 
 
Strong inhibition of metalloenzymes has often been achieved by direct coordination of 
catalytic metals within the active site. Three examples of such inhibition employed 
successfully in clinical drugs are the sulphonamides (as carbonic anhydrase inhibitors),12 
suberoylanilide hydroxamic acid (SAHA) as histone deacetylase inhibitor13 and L-captopril 
(Scheme 1), which was the first marketed anti-hypertension drug, targeting angiotensin I 
converting enzyme (ACE).14 Captopril binds to the catalytic zinc of ACE through 
coordination by a sulfhydryl group. Although captopril also shows some inhibitory activity 
towards other zinc metalloproteases, this is typically several orders of magnitude weaker than 
with ACE.14 
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Recently, Becker and colleagues 6 also identified captopril amongst the best inhibitors of H. 
influenzae DapE in a screen biased toward compounds containing zinc-binding groups 
(including thiols, carboxylic acids, boronic acids, phosphonates and hydroxamates). Captopril 
was found to be a low-micromolar inhibitor of DapE (IC50 = 3.3 µM, Ki = 1.8 µM) and had 
antimicrobial activity in bacteria (against E.coli). However, here we present evidence that 
DapE is not the main target of L-captopril antimicrobial activity in bacteria. 
 
Bacterial strains, plasmids, media and other materials 
 
Escherichia coli XL1-Blue was purchased from Stratagene. Salmonella enterica serovar 
Typhimurium DapE knockout-strain (TN5911) and the plasmid, pCM655/DapE, were kindly 
provided by Prof. Charles G. Miller.15 E-medium16 supplemented with 0.4% glucose and a 0.4 
mM concentration of the appropriate amino acids (Bachem) was used as a minimal medium, 
and LB-medium was used as a rich medium. As a supplement, meso-diaminopimelate 
(mDAP) was added at 1 mM (Bachem). L-captopril was purchased from Sigma Aldrich. 
Sodium ampicillin, tetracycline and chloramphenicol were used at final concentrations of 60, 
5 and 34 µg/ml, respectively, when added to either liquid or solid medium. Liquid cultures 
were aerated by shaking on a rotary shaker (250 rpm), and all growth incubations were at 
37°C for 19 hours. Electro competent cells of S.enterica and chemical competent cells of 
E.coli were prepared by standard protocols. IPTG and mDAP were used at a final 
concentration of 1 mM. Agar (used at 1.5 %) and agarose (used at 1 %) were purchased from 
Invitrogen. T4-DNA ligase and HindIII from New England Biolabs. All other chemicals were 
purchased from Applichem, unless otherwise specified.   
 
Methods 
 
An empty plasmid, pCM699, was derived from the plasmid, pCM655/DapE,15 by deleting the 
DapE gene by HindIII digestion and re-ligation of the vector backbone (Table 1). The strain 
TN5911 (chloramphenicol resistance), is a knock out strain for DapE and for several 
dipeptidases; therefore, mDAP has to be supplemented in both minimal and enriched media. 
An appropriate source of leucine and proline is also  required in minimal medium and 
supplementation with lysine provides better growth (Prof. Charles G. Miller; personal 
communication). Two strains were derived from the knockout-strain TN5911 by transforming 
the plasmids pCM655/dapE and pCM699 (strains TN5935 and TN5959, respectively). The 
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plasmids (pCM655/dapE and pCM699) were transformed into TN5911 by electroporation 
(1.8Kv, 0.1cm cuvettes) and recovered with 1 ml of SOC medium containing mDAP and 
chloramphenicol for 1 hour at 37°C in a shaking incubator and selected for plasmid encoded 
ampicillin resistance. A single colony of each strain TN5935 and TN5959 was picked and 
cultured in 5 ml of LB containing appropriate amounts of chloramphenicol, ampicillin, and 
mDAP over night at 37°C in a shaking incubator. The cultures of the two strains were diluted 
by 10 times (to dilute-out any remaining mDAP) and each strain was plated in a minimal 
medium supplemented or not with mDAP. In a similar manner, E.coli strains, TN5960 and 
TN5962, were derived from wild-type XL1-Blue by transforming the plasmid pCM699 and 
pCM655/DapE respectively. Analysis of soluble cell extracts of TN5960 and TN5962 by 
SDS-PAGE revealed the presence of an additional species of about 42KDa in cells harbouring 
pCM655/DapE (i.e. strain TN5962), corresponding to the expected size of the recombinant 
S.enterica DapE in E.coli. 
 
To test L-captopril inhibition, appropriate dilutions of each strain (e.g. TN5935 & TN5959) 
were spread on selection plates with and without mDAP. After spreading the cultures, sterile 
paper discs soaked in several concentrations of L-captopril were placed on each plate; 
alternatively, a given amount of compound was placed in powder form directly at a defined 
site on the agar, such that it could be covered by a paper disk, and subsequently 10µl of sterile 
water were added carefully on the disk. These selection plates were incubated over-night at 
37°C.  
 
Plasmids Genotype Remarks 
 
pCM655/DapE Plasmid with dapE 
gene 
Allows over-expression of DapE, thus rescuing 
DapE knockout strains (even in absence of mDAP 
supplementation). Also confers ampicillin-
resistance 
 
pCM699 Plasmid without 
dapE gene 
Confers ampicillin-resistance, but does not 
genetically rescue DapE knockout strains  
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Strains Genotype Remarks 
 
S.enterica 
 
  
TN5911 dapE knockout 
strain 
Strain does not grow in absence of mDAP 
supplementation 
 
TN5935 TN5911  
+ pCM655/DapE 
DapE is over-expressed from plasmid and 
strain can grow in absence of mDAP 
supplementation 
 
TN5959 TN5911  
+ pCM699 
Plasmid does not contain DapE and 
knockout strain does not grow in absence of mDAP 
supplementation 
E.coli 
 
  
XL1-Blue Wildtype  
(from Stratagene) 
Has endogenous DapE and 
can grow in absence of mDAP supplementation 
 
TN5960 XL1-Blue  
+ pCM699 
Plasmid does not contain DapE, but strain can grow 
in absence of mDAP supplementation due to 
endogenous DapE 
 
TN5962 XL1-Blue  
+ pCM655/DapE 
In addition to endogenous DapE, this strain has 
plasmid-encoded DapE over-expression (from 
S.enterica). 
 
Table 1. Summary of strains and plasmids used in this work.  
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Results 
 
First, we compared the growth of E.coli in the presence of L-captopril, with and without 
mDAP supplementation in the agar-medium, using a disk-diffusion assay (Figure 1 and Table 
2). We confirmed the modest inhibitory activity of L-captopril in E.coli, as previously 
reported. However, to our surprise, L-captopril antimicrobial activity was independent of 
mDAP supplementation in E.coli. Moreover, the extent of inhibition was also unaffected by 
heterologous expression of DapE (from Salmonella enterica) in E.coli (Figure 1c & 1d). 
 
Second, considering that over-expression of DapE from S.enterica in E.coli did not affect L-
captopril inhibition, we set-out to confirm that the DapE plasmid was functional for DapE 
expression. As previously reported 15, the DapE knock-out strain (TN5911) of S. enterica only 
grows when harbouring the plasmid carrying dapE gene (pCM655/DapE, within strain 
TN5935) or by supplementing the medium with mDAP, which is derived from the native 
product of DapE hydrolytic activity, L,L-DAP. Consequently, strain TN5935 (which harbours 
a plasmid-encoded dapE gene) grew even in the absence of mDAP supplementation, since it 
can produce its own DAP for cell-wall synthesis. As negative control, we corroborated that 
the knockout strain harbouring the corresponding “empty plasmid” (conferring ampicillin 
resistance but with no dapE gene; strain TN5959) did not grow in absence of mDAP 
supplementation.  
 
Third, we tested the growth inhibiting-activity of L-captopril in these various recombinant 
strains of S.enterica. We hypothesised that if L-captopril was inhibiting DapE in bacteria, 
then mDAP supplementation or DapE over-expression would alleviate the antimicrobial 
effects of the drug. Surprisingly, L-captopril inhibited the growth of TN5959 (harbouring an 
empty plasmid) despite the addition of mDAP (Figure 2 and Table 3). We also tested whether 
the modest L-captopril  inhibition could be overcome by DapE over-expression. Here also, we 
were surprised to find that similar L-captopril inhibition of strain TN5935 (over-expressing 
DapE), even when mDAP was additionally supplemented in the medium. 
 
The zone of inhibition was slightly more in strain TN5935 compared to TN5959, although 
this difference was very subtle and could only be seen when the paper disks were soaked at 
the concentrations 25mg/ml and 50mg/ml, but not when 20mg were added (Table 3); at the 
latter amount of compound, the extent of inhibition was significant and identical to that 
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observed in TN5959. We speculate that this marginally higher L-captopril inhibition in the 
strain over-expressing DapE (TN5935) compared with TN5959 is due to the high metabolic 
load of the cell caused by over-expression of DapE. 
 
Taken together, these data strongly suggest that L-captopril modestly inhibits both S.enterica 
and E.coli to a similar extent, but in a DapE-independent manner. 
 
 
Scheme 1. Structures of L- captopril and N-succinyl-L,L- diaminopimelic acid. 
 
Figure 1. DapE independent inhibition of E.coli by L-captopril. (A) the strain has constitutively 
expressed endogenous dapE gene and the medium was also supplemented with mDAP, (B) the strain 
has constitutively expressed endogenous dapE gene but the medium was not supplemented with 
mDAP, (C) the strain has over-expressed plasmid encoded DapE (in addition to the constitutively 
expressed endogenous DapE) and the medium was also supplemented with mDAP, (D) the strain has 
over-expressed plasmid encoded DapE (in addition to the constitutively expressed endogenous DapE) 
but the medium was not supplemented with mDAP. 
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Strain with  
endogenous DapE 
 
Supplemented with mDAP 
TN5960 
(Plasmid without dapE gene) 
TN5962 
(Plasmid with dapE gene) 
Yes No Yes No 
                                                                 Radius of zone of inhibition by L- captopril 
25mg/ml 
50mg/ml 
20mg 
0.2cm 0.2cm 0.2cm 0.2cm 
0.2cm 0.2cm 0.2cm 0.2cm 
1.2cm 1.2cm 1.2cm 1.2cm 
Table 2. Inhibition of E.coli growth by L-captopril. 
 
Figure 2. DapE independent inhibition of Salmonella enterica by L-captopril. The knockout-strain has 
plasmid encoded dapE gene but; (A) the medium is also supplemented with mDAP, (B) the medium is 
not supplemented with mDAP. The knockout-strain has no plasmid encoding dapE gene but; (C) the 
medium is also supplemented with mDAP, (D) the medium is not supplemented with mDAP. 
 
DapE-knockout strains 
 
Supplemented with mDAP 
TN5935 
(Plasmid with dapE gene) 
TN5959 
(Plasmid without dapE gene) 
Yes No Yes No 
                                                          Radius of zone of inhibition by L- captopril 
25mg/ml 
50mg/ml 
20mg 
0.1cm 0.1cm 0.0cm No growth 
0.5cm 0.5cm 0.1cm No growth 
1.7cm 1.7cm 1.7cm No growth 
Table 3. Inhibiton of Salmonella enterica growth by L-captopril. 
	
   25	
  
 
Discussion 
 
Diaminopimelic acid is an essential precursor for cell wall synthesis in many bacteria, 
including E.coli and S.enterica.4,17 Inhibition of DapE from H.influenzae in vitro and 
inhibition in Escherichia coli by L-captopril in bacteria was recently reported.5 In the process 
of enzymatically characterizing mutant variants of Salmonella enterica DapE, we decided to 
test the inhibition of DapE with L-captopril in bacteria. We hypothesised that if L-captopril 
was inhibiting bacterial growth by inhibiting DapE, then mDAP supplementation in the 
growth media would overcome drug-inhibition. However, to our surprise we found that L-
captopril inhibits the bacterial strains (S.enterica & E.coli) in a DapE-independent manner. 
 
The putative substrate binding site and the metal coordinating residues are very much 
conserved in the DapE of E.coli, S.enterica and H.influenzae, all of which are thought to have 
similar binuclear metal-centres and identical catalytic mechanism.7,9-11 Consequently, 
considering such structural and functional conservation among DapE from these various 
bacteria, it would be expected that L-captopril is able to inhibit the different homologs in a 
similar manner, proving potentially active as a broad-selectivity antibiotic. It is noteworthy 
that different isoforms of DapE (e.g. from different organisms or with different metal 
contents) could be inhibited differently, thereby making it difficult to find a single broad-
spectrum antibiotic targeting DapE. Our data show that L-captopril is not a broad-spectrum 
antibiotic targeting DapE in bacteria, because it neither targets DapE in E.coli nor in 
S.enterica. Since the extent of inhibition by L-captopril in bacteria was similar in all of our 
experiments in E.coli and S.enterica and independent of DapE, we suggest that the modest 
antimicrobial activity of this compound is probably due to inhibition of hitherto-unidentified 
metalloproteins other than DapE. 
 
In summary, our results show that, despite the reported inhibition of DapE from H.influenzae 
by L-captopril in vitro, it is very unlikely that DapE inhibition contributes to any significant 
antimicrobial activity in gram-negative bacterial cultures. Therefore, L-captopril is a modest 
antibiotic, inhibiting gram-negative bacteria at high doses, but its mechanism of action or 
molecular target remains unknown.  
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Finally, considering that DapE is a promising antibiotic target, the failure of a lead-compound 
that inhibits DapE in vitro to show any measurable anti-DapE effect in bacteria provides a 
sobering reminder of the difficulty of translating in vitro data to effects in vivo, even in pure 
microbiological cultures. However, despite our finding that captopril does not lead to DapE 
inhibition in bacteria, the development of other (more effective) DapE inhibitors in vitro and 
in vivo continues to be a very worthy goal and a promising line of research toward new 
antibiotics. We suggest that mDAP supplementation, as described here, will offer a facile and 
very robust method for confirming the selectivity of novel antibiotics targeting DapE in 
bacteria.  
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CHAPTER 3 
 
Zinc-selective Inhibition of the Promiscuous Bacterial Amide-
Hydrolase DapE: Implications of Metal Heterogeneity in 
Evolution and Antibiotic Drug-Design 1 
 
Summary   
 
The development of resistance to virtually all current antibiotics makes the discovery of new 
antimicrobial compounds to novel protein targets an urgent challenge. The dapE-encoded N-
succinyl-L,L-diaminopimelic acid desuccinylase (DapE) is an essential metallo-enzyme for 
growth and proliferation in many bacteria, acting in the desuccinylation of N-succinyl-L,L-
diaminopimelic acid (SDAP) in a late stage of the anabolic pathway towards both lysine and a 
crucial building block of the peptidoglycan cell wall. L-captopril, which has been shown to 
exhibit very promising inhibitory activity in vitro against DapE and has attractive drug-like 
properties, nevertheless does not target DapE in bacteria effectively. Here we show that L-
captopril targets only the Zn2+-metallo-isoform of the enzyme, whereas the Mn2+-enzyme, 
which is also a physiologically-relevant isoform in bacteria, is not inhibited. Our finding 
provides a rational for the failure of this promising lead-compound to exhibit any significant 
antibiotic activity in bacteria and underlines the importance of addressing metallo-isoform 
heterogeneity in future drug design. Moreover, to our knowledge, this is the first example of 
metallo-isoform heterogeneity in vivo that provides an evolutionary advantage to bacteria 
upon drug-challenge 
 
 
 
 
 
 
	
   29	
  
Introduction 
 
It has been estimated that about 25 000 people die in Europe alone every year from an 
infection due to common antibiotic-resistant bacteria, causing an economic burden in excess 
of 1.5 Billion Euro per year.2 Similar alarming statistics are reported around the world, 
making the current inevitable rise of antibiotic-resistance to our limited subset of clinically 
useful drugs an issue of great concern.3,4 It is therefore crucially important and urgent that 
new protein targets are identified and that their specific inhibitors are developed.  
 
DapE, N-succinyl-L,L-diaminopimelic acid desuccinylase of the meso-diaminopimelate 
(mDAP)/lysine biosynthetic pathway of bacteria has been identified as an attractive potential 
antibiotic target for two main reasons:5 i) the growth of many bacteria is highly dependent of 
the biosynthesis of lysine and diaminopimelic (DAP) acid, which are essential for protein 
synthesis and elaboration of their peptidoglycan cell wall, respectively 6-8 and ii) both DAP 
and lysine are synthesized by the dap operon bacterial enzymes and no similar pathways take 
place in humans. 
 
L-captopril was identified as a low-micromolar inhibitor of the H.influenzae DapE enzyme in 
vitro.9 Considering that L-captopril is a marketed drug against hypertension10 one may 
suppose that the compound already exhibits attractive pharmacokinetic properties. Moreover, 
considering the structural and functional conservation among DapE from various bacteria, one 
would expect that L-captopril may inhibit various bacterial homologues in a similar manner, 
thus potentially proving to be a broad-selectivity antibiotic. Disappointingly, however, L-
captopril exhibited only very modest antimicrobial activity when tested in bacteria (including 
strains of S.enterica and E.coli). Moreover, this weak activity was revealed to be totally 
DapE-independent.11 
 
The failure of a promising drug-like compound to exhibit any significant antimicrobial effect 
in vivo or to target the enzyme target identified in vitro is perplexing and acts as a sobering 
reminder of the difficulty of translating in vitro data to effects in vivo. In an attempt to 
overcome this initial set-back, we aimed at understanding why L-captopril should fail to have 
any significant antimicrobial potency in bacteria. Here, we present a simple answer to this 
conundrum, based on the surprising metal-selectivity of L-captopril and its inability to inhibit 
all microbiologically relevant metallo-isoforms. Further, our findings imply that heterogeneity 
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in metal content of metallo-enzymes may confer selective advantages.  
 
Materials and Methods 
 
Construction of C-terminus polyhistidine-tagged DapE (DapE-C6His) 
 
A pET28b-based plasmid (Novagen) for DapE over expression was constructed according to 
published methods.12 Briefly, the 1.2kb dapE gene was PCR amplified from the plasmid 
pCM655dapE by using the primers from microsynth;  
F-SEQpCM655  (5’ GCGTACGTCGCGACCGCGGACATGT 3’)  
R-pCM655XhoI  (5’ AGCCAAGCCTCGAGGGCGACGAGCTGTTCC 3’)  
Pfu turbo polymerase (Stratagene) and sub-cloned into pET28b plasmid (Novagen) at the 
restriction sites HindIII and XhoI (Biolabs). 
 
Expression and purification of recombinant DapE-C6His 
 
The expression plasmid, pET28b-DapE, was transformed into strain BL21(DE3), Stratagene; 
the pre-culture was made in LB-medium with 30 µg/ml kanamycin and 2% glucose at 37°C 
and the over-expression was induced with 1 mM isopropyl-1-thio-β-D-galactopyranoside 
(IPTG) when the OD600 is between 0.5 and 0.8, in LB-medium containing 30µg/ml 
kanamycin at 20°C throughout. The cells were harvested after 6 hours of IPTG induction and 
the cell pellet was frozen at -20°C, which was then thawed on ice and re-suspend in lysis 
buffer (50 mM tricine pH 7.8, 0.5 M NaCl, 1 mM PMSF, 3 µg/ml DNaseI and 5 µg/ml 
lysozyme) and the cell-lysis was carried out at 37°C, 200 rpm for 1 hour. The soluble protein 
fraction was transferred into a fresh bottle at 4°C after the centrifugation at high speed (9000 
g) for 30 minutes in a pre-cooled (4°C) centrifuge. 
 
The soluble protein fraction was filtered by 0.45 µm filter & the loading buffer (50 mM 
tricine pH 7.8 & 0.5 M NaCl) and elution buffer (50mM tricine, 0.5 M NaCl & 0.5 M 
imidazole and the final pH was adjusted to 7.8) were filtered by 0.2 µm filter. Filtered DapE-
C6His protein was purified on HiTrap 5 ml chelating HP columns (Cat. # 17-0409-03, from 
GE) loaded with 0.1 M ZnCl2 in 50 mM tricine with ÅKTA Purifier-10, from GE.  
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Removal of the labile metal from the purified protein solution was achieved by 3 step 
sequential dialysis. First, dialysis against 10 L of 50 mM tricine pH 7.8 with 1 mM 1,10-
phenanthroline, second dialysis against 10 L of 50 mM tricine pH 7.8 with 5 mM 
ethylenediaminetetraacetic acid (EDTA) and third dialysis with 50 mM de-metallated tricine 
pH 7.8. Each dialysis is for 8 to 12 hours at 4°C using the dialysis bags with an approximate 
molecular weight cut-off of 6 to 8 KDa (Cat. # 132655, Spectrumlabs). Chelex-100 (Biorad) 
chelating ion exchange resins were used for the de-metallation of the buffer, 50 mM tricine 
pH 7.8 for dialysis. 
 
Purified DapE protein from S.enterica exhibited a single band on SDS-PAGE, indicating a 
molecular weight of approximately 42 KDa. Protein concentrations were determined by using 
the Pierce BCA protein assay kit (Cat. # 23227, Thermo scientific). The yield of the purified 
DapE protein was about 1 mg/L of bacterial culture.  
 
Synthesis of SDAP. 
 
N-succinyl-L,L-diaminopimelic acid (SDAP) was synthesized in liquid phase through a 
standard coupling procedure between mono-tert-butyl succinate and enantiopure mono-tert-
butyl protected L,L-diaminopimelic dimethyl ester (protected DAP), using O-Benzotriazole-
N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) as coupling agent. The 
product of the coupling was then conveniently deprotected by standard cleavage of the 
protecting groups. DAP was previously synthesized according to published protocols via 
olefin cross-metathesis between enantiopure Boc-L-Allylglycine-OMe and Cbz-L-
Vinylglycine-OMe, in yields above 70%.13 
 
DapE kinetic assays. 
 
The enzymatic assays were carried out in triplicate in 50 mM tricine pH 7.8 at 37°C, using the 
purified DapE-C6His to a final concentration of 1 ng/µl. The final substrate concentration of 
native substrate (SDAP) was 20 mM in a reaction volume of 50 µl. Initially the DapE enzyme 
was pre-incubated with metals (0.2 mM ZnCl2 & 0.5 mM MnCl2 for native substrate) at 37°C 
for an hour and then with the inhibitor for another 10 minutes. L-captopril was purchased 
from Sigma-Aldrich. In all cases the reactions were initiated by adding substrate. The 
enzymatic reaction was followed by measuring the hydrolysis of the peptide bond of the 
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substrates.14 Readings were carried out every 2 minutes for about 3 hours at UV230nm in UV 
transparent 96-well plates (Cat # 7.675 801, Greiner) using a TECAN Safire plate reader.  
 
Growth assays. 
 
Bacterial growth assays were carried out with strain TN5911, a knock out strain for DapE and 
for several dipeptidases; therefore, mDAP has to be supplemented in both minimal and 
enriched media. An appropriate source of leucine and proline is also required in minimal 
medium and supplementation with lysine provides better growth (Prof. Charles G. Miller; 
personal communication). For DapE expression, strain TN5911 was transformed with the 
plasmid pCM655/DapE to form strain TN5935.11,12  
 
The metal-dependent anti-microbial activity of L-captopril was monitored by measuring the 
growth curves of the TN5935 in LB-medium containing L-captopril (0, 1 mM, 5 mM, 25 mM, 
100 mM & 300 mM) under native activity selection (no mDAP supplementation) and under 
no selection (supplemented with 1 mM mDAP) and with and without 0.35 mM metal (MnCl2 
or ZnCl2) supplementation. All measurements were carried out at least in duplicate. The main 
cultures were grown and the OD600 was measured in flat bottom 96-well plate (200 µl 
culture/well) in a plate reader (TECAN Safire) at 37°C for every 16 minutes. The main 
cultures were started by adding the pre-culture of OD600 ~1 to an initial OD600 between 0.1 
and 0.2.  
 
The effect of the metals on DapE enzyme activities in bacteria was monitored by measuring 
the growth curves of the TN5935 under no selection, selection for native & promiscuous 
activities with and without 0.35 mM metal salt (MnCl2 or ZnCl2) supplementation. These 
growth curves were measured form the cultures of minimal medium (1% MgSO4.7·H2O, 10% 
citric acid·H2O, 50% K2HPO4, 17.5% NaHNH4PO4·4H2O, 0.4% glucose, 0.4 mM proline, 0.4 
mM lysine, 0.4 mM leucine or Asp-Leu, 1 mM IPTG and 1mM mDAP) by following the 
OD600 every 4 hours at 37°C at 200 rpm. The cultures were started by adding the pre-culture 
of LB-medium of OD600 ~1 to an initial OD600 between 0.1 and 0.2, which corresponded in 
this case to 0.4 ml of overnight LB-medium culture in 100 ml of minimal medium in a 1 L 
Erlenmeyer flask. We carried out a control culture to confirm that at this dilution of rich LB-
medium in minimal medium (250-fold dilution), there is insufficient carry-over of leucine to 
allow for any detectable growth of the dapE knockout strain (TN5911) when supplementing 
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with mDAP. 
 
Structural modelling.  
 
A homology model of the Salmonella enterica DapE model was built with SWISS-
MODEL.15 The di-zinc Haemophilus influenzae X-ray structure [PDB: 3IC1] sharing 61% 
identity with S.enterica without waters was used as a modelling template. The resulting model 
was energy minimized using the Yasara energy minimization server.16 The L-captopril 
structure [PDBe: X8Z] was then placed manually into the active site and the resulting mono- 
and di-zinc structures energy minimized with fixed zinc ions using Maestro.17 Only few 
ligand conformations without steric clashes were found satisfying the constraints of metal-
coordination imposed and only the orientation in the final model occupies the binding pocket 
to any large extent, thus favouring free energies of binding. Model figures were all drawn 
with Pymol.18  
 
Results 
 
Metal substitution changes L-captopril inhibition in vitro. 
 
DapE was active as an SDAP desuccinylase in vitro both in its Zn2+ mono-metallated form 
(Zn/-) or as a Zn2+ binuclear (Zn/Zn) or mixed (Zn/Mn) form, with comparable Vmax (Scheme 
1 & Table 1). Addition of L-captopril in vitro inhibited the catalytic activity of the (Zn/-) or 
(Zn/Zn) metallated isoforms of DapE, with an IC50 of 10 µM and 28 µM at 20 mM substrate, 
respectively (Figure 1). However, no significant inhibition of the Zn/Mn isoform was found 
even at 1 mM L-captopril. 
 
 
Scheme 1. L-captopril inhibitor and substrates of DapE used in this study. Elements common to the 
three molecules are highlighted in red. 
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metallo-­‐isoform	
  
DapE	
  
Vmax	
  	
  
(μmol/L	
  s-­‐1)	
  
kcat	
  	
  
(s-­‐1)	
  
	
  
Zn/-­‐	
  
	
  
18.23	
  
	
  
309	
  
Zn/Zn	
   39.81	
   677	
  
Zn/Mn	
   64.99	
   1104	
  
 
 
Table 1. DapE desuccinylation activity in vitro. a Vmax and kcat values of desuccinylase activity of 
different metallo-isoforms of recombinant DapE from Salmonella enterica typhimurium. 
 
 
Manganese isoform is present in vivo  
 
Traditionally, it has been considered that Zn2+ is the native and physiologically-relevant metal 
of DapE. However, the enzyme presents also a promiscuous dipeptidase activity that is 
dependent on the presence of manganese ions (Mn2+), which can also be selected in vivo in an 
leucine auxotroph strain using Asp-Leu as a substrate.12 Since this non-native dipeptidase 
activity occurs in vitro only when the labile, co-catalytic Zn2+ is replaced by Mn2+ to form a 
mixed Zn/Mn binuclear centre, then it is surmised that the DapE-dependent promiscuous 
activity in bacterial cultures also arises from Mn2+-metallo-isoforms of DapE in vivo.12 
 
 
Figure 1. Inhibition of desuccinylase activity of different DapE metallo-isoforms by L-captopril. 
Measurements were carried out in triplicate and error bars represent the standard deviation from the 
mean. 
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When selecting for the native desuccinylase activity in bacteria, the conditions in which no 
metal was added and where Zn2+ was supplemented showed similar growth; in contrast Zn2+ 
slowed-down the growth of cell-cultures when selecting for dipeptidase activity, which 
suggests that Zn2+ is deleterious for the promiscuous activity of DapE, but not for its native 
activity (Figure 2). DapE was able to desuccinylate SDAP in its Zn/-, Zn/Zn and Zn/Mn 
metallo-isoforms in vitro, albeit to different extents, with the following trends for kcat: Zn/Mn 
> Zn/Zn > Zn/- (Table 1). S.enterica grew appreciably better in Mn2+-supplemented media 
when selected either for native or promiscuous activity (Figure 2). Therefore, it appears that 
addition of Mn2+ promotes dipeptidase activity of DapE both in vivo and in vitro, whereas 
Zn2+ inhibits the dipeptidase activity, presumably by competing with Mn2+ for the labile 
metal-binding site of DapE. 
 
We conclude from these observations that: i) metallation of DapE can be influenced by metal-
supplementation with either Zn2+ or Mn2+; ii) Mn2+-metallation is growth-limiting in non-
supplemented medium, particularly when selecting for the dipeptidase activity and iii) that the 
Mn2+ isoform may be normally present in vivo but is not the only metallated species of DapE 
that occurs.  
 
Zn2+ supplementation makes bacteria more susceptible to L-captopril inhibition 
compared to Mn2+ 
 
Having concluded from growth profiles that metal supplementation of bacterial cultures can 
influence the state of metallation of DapE, we next investigated whether metal-
supplementation also affected susceptibility to L-captopril in bacterial cultures. We reasoned, 
since L-captopril targets only the Zn2+-isoform of DapE in vitro and since metal 
supplementation can influence the metallation of DapE in vivo, that we may be able to 
influence the sensitivity of bacterial cultures to L-captopril through metallation of DapE. 
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Figure 2. Growth curves of bacterial cultures selected for native (desuccinylase) DapE activity (A) or 
promiscuous (dipeptidase) DapE activity (B) in absence or presence of Zn2+ or Mn2+ supplementation. 
Note that Mn2+ accelerates growth of the culture appreciably when selecting both for native and 
promiscuous activity. In contrast, Zn2+ slows down growth of the culture appreciably when selecting for 
promiscuous activity but has little effect on proliferation when selecting for native activity. Plotted are 
fitted curves from means of duplicate cultures, with individual values comprised in the symbols. The 
values plotted are representative from two independent experiments with similar findings. 
 
First, we confirmed that L-captopril was toxic in a dose-dependent manner, shown by 
bacterial growth-curves in rich medium at different inhibitor concentrations (Supplementary 
Figure S1). Second, in the growth conditions tested, in rich medium and 25 mM L-captopril, 
metal supplementation with either divalent Zn or Mn lowered L-captopril toxicity. The 
influence of metal supplementation on bacterial growth under these conditions was much 
larger in presence of 25 mM L-captopril than in the absence of the drug (Figure 3): Mn2+-
supplemented cultures clearly showed better growth as compared to Zn2+ supplemented or 
especially non-metal-supplemented cultures, which were more  susceptible to L-captopril 
inhibition. The growth-profile in presence of L-captopril was Mn2+>Zn2+>no metal. 
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Intriguingly, L-captopril inhibition of DapE in vitro has exactly the complementary activity 
profile: L-captopril inhibition Mn2+<Zn2+<no metal. 
 
Despite the metal-dependent effect of L-captopril, bacterial growth in absence of selection for 
DapE activity (i.e. with mDAP supplementation) showed that the toxicity of this drug is 
largely independent of DapE activity (Figure 3B), confirming our previous finding that this 
essential enzyme is not the main target of inhibition of L-captopril in vivo and suggesting that 
other metalloproteins may also be the main targets of L-captopril.11  
 
We conclude that at least some of the targets of L-captopril are metal-dependent, i.e. metal-
supplementation decreases sensitivity to L-captopril. The finding that Mn2+ supplementation 
is more protective than Zn2+ supplementation is consistent with the notion that L-captopril has 
a preference for Zn2+-containing targets, at least some of which may also be functionally 
active with Mn2+. We also surmise that the failure of L-captopril to exhibit any significant 
DapE-selective antibiotic activity in bacteria is due to the existence of sufficient Zn/Mn 
isoform, which is not susceptible to L-captopril inhibition. 
 
Figure 3. Effect of metal supplementation on growth curves of bacterial cultures selected for DapE 
activity (A) or non-selected (B), in absence of L-captopril (left) or in presence of 25 mM L-captopril 
(right). Cultures were grown in LB broth either in presence or absence of mDAP for selection of native 
(desuccinylase) activity of DapE. The effect of divalent Zn or Mn was tested and compared to the 
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absence of metal supplementation (no metal). Note that L-captopril toxicity is dependent on metal-
supplementation and that Mn2+ is more protective than Zn2+, although the toxic effect of the drug is 
largely independent of DapE activity. Means of measurements from quadruplicate cultures are plotted 
with standard deviations shown as error bars. 
 
Model of L-captopril inhibition supports that thiol is the Zn2+-binding group. 
 
We created a model of S.enterica DapE (Figure 4) based on the high-resolution crystal 
structure of the homologous enzyme from Haemophilus influenzae reported by Nocek et al..19 
The DapE enzyme is a dimer, each monomer of which contains two domains: a dimerization 
domain and a catalytic domain. The active site of the enzyme can contain either two or one 
zinc ions. The strongly-bound Zn2+ is referred to as Zn1, whereas the Zn2+ occupying the site 
of the labile metal (M2, which can be either Zn2+ or Mn2+), is referred to as Zn2. 
 
 
Figure 4. Model of S.enterica DapE based on the crystal structure of H.influenzae DapE (PDB: 3IC1), 
with L-captopril docked to the (A) di-zinc and (B) mono-zinc catalytic metal center. Only the side-
chains of important residues for catalysis are drawn and labelled, i.e. coordinating amino acids and the 
catalytic base (E134). L-captopril is drawn in stick-form with each type of atom colored differently: 
green carbon; blue nitrogen; red oxygen; yellow sulfur and white hydrogen. The coordination bonds of 
L-captopril to the active-site metals are drawn in yellow: in both the mono- and di-zinc form, the L-
captopril carbonyl group of the amide coordinates to the Zn1, whereas the L-captopril thiol group can 
additionally coordinate either to Zn2 in the di-zinc structure (A) or to Zn1 in the mono-zinc structure, to 
form a 6-membered ring (B). Figure courtesy of Dr. Tobias Schmidt & Dr. Stefan Nicolet. 
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To generate the model of L-captopril binding to the active site, we imposed some constraints 
based on prior knowledge of DapE and L-captopril as a substrate analogue (Scheme 1). First, 
as in the suggested catalytic mechanism of DapE,19 we propose that the carbonyl group of the 
amide coordinates to the catalytic metal that acts as a Lewis acid (Zn1). Second, since 
captopril binds to the catalytic zinc of Angiotensin Converting Enzyme (ACE) through 
coordination by the sulfhydryl group10 and since we found experimentally that the nature of 
the co-catalytic metal (M2, either Zn2+ or Mn2+) influences inhibition by L-captopril, we 
chose to place the sulfhydryl group oriented toward this second metal. 
 
Divalent manganese behaves similar to magnesium in having a preference for oxygen ligands, 
although Mn2+ is more receptive of nitrogen ligands; in contrast, zinc prefers nitrogen and 
sulfur as ligands and, in general, a lower coordination number.20 Consequently, our model 
provides a reasonable and straightforward qualitative explanation for the metal-dependent 
selectivity of L-captopril inhibition of DapE: the presence of Mn2+ does not allow strong 
coordination by the sulfhydryl group, whereas either the absence of a co-catalytic metal or the 
presence of a second Zn2+ allows coordination with the sulfur liganding either Zn2 or Zn1, 
respectively.  
 
Discussion 
 
Implications for drug development.  
 
L-captopril was the first marketed anti-hypertension drug, targeting the Zn-metalloprotease 
Angiotensin I Converting Enzyme (ACE) through coordination of the catalytic metal by a 
sulfhydryl group, with low nM affinity.10 However, L-captopril has also shown inhibitory 
activity towards a variety of other zinc metalloproteases, although this is typically several 
orders of magnitude weaker than with ACE.21 Recently, L-captopril was identified also as a 
low-micromolar inhibitor of H.influenzae DapE (IC50 = 3.3 µM). We found that L-captopril 
inhibited the Zn/Zn isoforms of S.enterica DapE with IC50 values comparable to those of the 
H.influenzae enzyme (i.e. IC50 of 10µM vs 3.3 µM, respectively), providing further evidence 
for the similarities in structure and function of the active sites of DapE of different species.22-
26 The low-micromolar affinity of L-captopril for the Zn/- and Zn/Zn isoforms of DapE could 
be seen as a reasonable starting point for further optimisation of this lead compound,5,6 akin to 
what succinyl-proline was for ACE. 10,21 However, note that L-captopril at the concentrations 
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at which it inhibits DapE might cause hypotension in normo-tensive individuals, which would 
warrant further development of its antibiotic properties. Moreover, at this low-micromolar 
level of affinity some off-targets are likely to occur, as indeed suggested by the poor activity 
of L-captopril 11 and by the general protective effect of Zn2+ and especially Mn2+ 
supplementation (Figure 3).  
 
We were nevertheless initially very surprised that we could detect no evidence of L-captopril 
inhibiting DapE activity in vivo and that the compound had such a modest antimicrobial 
activity, despite low-micromolar affinity of this drug in vitro for an essential enzyme. We 
now forward the proposal that a crucial contribution to this low antibiotic activity is that L-
captopril does not target one of the physiologically relevant isoforms of DapE, i.e. the Zn/Mn 
form of the enzyme. 
 
It is generally acknowledged that any screen (or selection) should reflect the desired result as 
closely as possible, because 'you get what you screen for'.27 Becker and colleagues 6 identified 
L-captopril as an inhibitor of DapE in a screen biased toward compounds containing zinc-
binding groups, which included thiols, carboxylic acids, boronic acids, phosphonates and 
hydroxamates and using the Zn-form of DapE of H.influenzae as a target in vitro. 
Consequently, a Zn-selective compound was identified with low micromolar affinity in vitro. 
Our discovery offers a plausible explanation for the failure of an apparently promising 
compound to show any DapE-targeted antimicrobial activity:11 the Zn/Mn mixed-metal 
isoform, which is not inhibited by L-captopril, is normally present in bacteria, as originally 
suggested by Broder and Miller 12 judging by the presence of a selectable Mn2+-dependent 
promiscuous activity, which we confirmed here also by exploring bacterial growth upon 
metal-supplementation of cultures.  
 
Exact knowledge of the metallation state of proteins in vivo is often thwarted with 
experimental difficulties.28-30 Moreover, metallation may exhibit strong dependence on cell-
context, differing for example in different media, cell-locations or in different species.31,32 
Several other examples have been reported where incomplete knowledge of the 
physiologically-relevant metal has hindered drug development. For example, potent inhibitors 
of methionine aminopeptidase discovered in vitro, which were active against either Co2+ or 
Mn2+-isoforms of the enzyme, failed to have any of the expected antibacterial activity in 
vivo.33-35 It was later suggested that Fe2+ is the native cofactor in E.coli, prompting a move 
	
   41	
  
either toward Fe2+-selective inhibitors that exhibited antimicrobial activity 36,37 or, in what 
may be called a “bet-hedging move” in absence of a clear candidate, toward exploring 
selectivity against a plethora of different metallo-isoforms.38 Similarly, peptide deformylase is 
another bacterial metalloenzyme and promising antibiotic target 39-41 that was originally 
thought to be a Zn-metalloenzyme in E.coli 42 but was later shown instead to contain Fe2+, a 
metal that due to its tendency to oxidize in air, leads to facile loss of enzyme activity.43 
However, the precise identity of the metal-in peptide deformylase may be species-specific, 
since another bacterial pathogen, Borrelia burgforderi, does use Zn2+ in this enzyme.44 
Despite considerable interest in peptide deformylase inhibitors in recent years 41 it appears 
that little attention has been paid to the issue of metallo-selectivity of drugs targeting this 
essential enzyme. 
 
Implications for evolution.  
 
In general, the presence of different metal ions in metalloenzymes can maintain the overall 
structure of the active site, but provide alternative coordination interactions with substrates 
and inhibitors. It has already been pointed out that non-strict metal incorporation can be used 
as a facile way to create catalytic diversity.45 For example, metal-heterogeneity has been 
proposed to have evolved in the carbonic anhydrase of marine diatoms that are challenged 
with low Zn-availability, thereby acquiring the capability of using either Zn2+ or Cd2+ in the 
active site of this essential enzyme.46 Indeed, we suggest that such metal-ambiguity and the 
resulting promiscuous behaviour in vivo, which may be considered a further example of 
“messiness in biology”,47 is in fact a more general survival strategy, for example to avoid 
facile drug inhibition of an essential enzyme like DapE. To our knowledge, this may be the 
first example of metal-promiscuity providing a source of (non-genetic) diversity that confers 
an intrinsic survival advantage in defending against potential inhibitors, namely to the 
synthetic drug L-captopril, but also likely against other naturally-occurring dipeptide-like 
compounds. Considering the importance of diversity as a driver of Darwinian evolution, we 
speculate that such metal-promiscuity may be much more common than hitherto thought, not 
only to provide substrate promiscuity in the development of new catalytic function, but also 
promiscuity for inhibitor-escape. 
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Conclusions 
 
In summary, DapE in bacteria is heterogeneous, containing various metallated forms –mono-
metallated with Zn2+ or binuclear with Zn2+ or Mn2+– all of which are active as a 
desuccinylase, the essential and native function of the enzyme. We also conclude that the 
Zn/Mn binuclear isoform, which is very likely to present in vivo as judged by bacterial 
selection of the promiscuous dipeptidase activity of DapE, is not inhibited by L-captopril, thus 
providing a mechanism of escape against this potential antibiotic. Such metal heterogeneity 
and resulting promiscuous properties may confer important selective advantages, including 
escape of inhibition, and therefore may have been selected for in evolution. Finally, the 
discovery of metal-selective inhibition of DapE that we describe here paves the way toward 
the discovery of compounds with improved antimicrobial properties. Our efforts are now 
directed toward finding novel inhibitors that target also the physiologically-relevant Mn2+ 
isoform of DapE. 
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Supplementary Figure S1. Concentration-dependent inhibition of bacterial growth with L-captopril. 
S.enterica containing a plasmid expressing DapE (strain TN5935) was grown in L.B. medium in 
absence of mDAP supplementation, i.e. under selection for native DapE activity.	
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CHAPTER 4 
 
Enzymatic Activation by Inhibition:  
Kinetic Cooperativity in the Bacterial Amide-Hydrolase DapE 
and Implications for Antibiotic Drug-Design 
 
 
Abstract. 
 
There is an urgent need to discover and develop novel antibiotics to fill the repertoire of drugs 
available to fight infections, which is being depleted alarmingly by the development of drug 
resistance. The dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) is 
an essential enzyme of the anabolic pathway toward lysine and the peptidoglycan cell wall in 
many bacteria and thus a promising target for antibiotic drug-design. The understanding of the 
exact enzymatic mechanism of this enzyme may thus facilitate the development of novel 
effective antimicrobial drugs. Here we show that DapE exhibits positive kinetic cooperativity, 
which we postulate arises from activation of one of the two monomers upon binding of a 
substrate or substrate analogue to the other monomer. Such cooperativity leads to the 
counterproductive effect of effective activation of enzyme activity by suboptimal dosage of 
competitive inhibitors occurring within a range of substrate concentration that is expected to 
be physiologically relevant. We suggest that such cooperativity as observed for DapE 
provides a general evolutionary strategy for bacteria for maximizing escape of inhibition by 
substrate analogues. Moreover, such mechanism of activation by naturally-occurring 
dipeptides at concentrations that may be physiologically relevant provides an additional 
mechanism of control of enzyme activity. Finally, our findings also imply the necessity to 
search for drugs that do not induce cooperativity or, alternatively, that it may be easier to 
develop effective drugs against isoforms of DapE that do not exhibit such positive 
cooperativity. 
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Introduction 
 
There is an urgent need to develop novel antibiotics. In Europe alone, every year 25’000 
people die in hospitals due to bacteria that are antibiotic resistant. As well as the human 
tragedy that it entails, antibiotic resistance is estimated to cost in excess of €1.5 billion each 
year.1 
 
The bacterial amide metallohydrolase DapE is an essential enzyme in most Gram-negative 
and many Gram-positive bacteria, being involved in anabolism of both the protein-amino acid 
lysine and of diaminopimelic acid (DAP), which is a crucial cross-linker of the peptidoglycan 
cell wall (Figure 1). The enzyme’s native function is desuccinylation of N-succinyl-L,L-
diaminopimelic acid.2 Considering its importance for many bacteria, including many 
pathogens, and that it is involved in a metabolic pathway that does not occur in humans, this 
enzyme has been postulated as a potential antibiotic target.3 As well as its native 
desuccinylase activity, the DapE enzyme of S.enterica typhimurium also exhibits a 
promiscuous manganese-dependent aspartyl dipeptidase activity.4 The structure of several 
putative bacterial DapE enzymes are available; of these, the best-characterised isoform is a 
recombinant form from H.influenzae, 5-11 which is a dimer, with each monomer containing a 
dimerisation domain and a catalytic domain. Structures were obtained with each active site 
either a monometallated-Zn or as a bi-metallated Zn/Zn form, both of which metalloisoforms 
are catalytically active 6. 
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Figure 1. Overview of bacterial cell-wall composition in Gram-positive and Gram-negative bacteria. 
Graphics courtesy of Dr. Stefan Nicolet. 
 
We have been interested in detailing mechanistic aspects of DapE in view of its potential as 
an antibiotic target. In particular, we have been intrigued by the failure of a low-micro molar 
inhibitor of the enzyme in vitro to target DapE in vivo.12 Here, we identify enzyme 
cooperativity as potentially contributing to the failure of a promising lead-compound in vitro 
to exhibit any detectable DapE-targeted antimicrobial activity. 
  
Organism  PDB Number 
 
Legionella pneumophila 3PFE 
Haemophilus influenza 3IC1, 3ISZ, 4H2K (for the latter, only catalytic domain) 
Staphylococcus aureus 3KHZ, 3KHX, 3KI9 
Vibrio cholerea 3T68, 3T6M (both only catalytic domain) 
Corynebacterium glutamicum 3TX8 
Neisseria meningitides 1VGY 
 
Table 1. List of proteins labeled as DapE in PDB database. 
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 Materials and Methods 
 
Cloning and expression of C-terminus polyhistidine-tagged DapE (DapE-C6His) 
 
A pET28b-based plasmid (Novagen) for DapE over expression was constructed according to 
published methods.4 The 1.2kb dapE gene was amplified by PCR by using the primers from 
microsynth, F-SEQpCM655 (5’ GCGTACGTCGCGACCGCGGACATGT3’) & R-
pCM655XhoI (5’ AGCCAAGCCTCGAGGGCGACGAGCTGTTCC 3’) from the plasmid 
pCM655dapE, with Pfu turbo polymerase (Stratagene) and sub-cloned into pET28b plasmid 
(Novagen) at the restriction sites HindIII and XhoI (Biolabs). Bacterial strain BL21(DE3), 
Stratagene, was used for the protein expression. For the over-expression of DapE protein the 
LB-medium with 30 µg/ml kanamycin was inoculated with overnight pre-culture in LB with 
2% glucose at 37°C. When the OD600 reached between 0.5 and 0.8, the main culture was 
induced with 1mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) and the temperature 
before and after induction was maintained at 20°C. The cells were harvested after 6 hours of 
IPTG induction and the cell pellet was frozen at -20°C. 
 
Purification of recombinant DapE-C6His 
 
The frozen cell pellet of the eprotein expression was then thawed on ice and re-suspend in 
lysis buffer (50 mM tricine pH 7.8, 0.5 M NaCl, 1 mM PMSF, 3 µg/ml DNaseI and 5 µg/ml 
lysozyme). The cell-lysis was done at 37°C, 200 rpm for 1 hour. And the soluble fraction was 
separated by centrifugation (pre-cooled, 4°C, centrifuge) and the clear soluble protein fraction 
was further centrifuged at high speed (9000 g) for 30 minutes and transferred into a fresh 
bottle at 4°C. The soluble protein fraction was filtered by 0.45 µm filter and the loading 
buffer (50mM tricine pH 7.8 & 0.5 M NaCl) and elution buffer (50mM tricine, 0.5 M NaCl & 
0.5 M imidazole and the final pH was adjusted to 7.8) were filtered by 0.2 µm filter. DapE-
C6His protein was purified on HiTrap 5 ml chelating HP columns (Cat. # 17-0409-03, GE 
health care) loaded with 0.1 M ZnCl2 in 50mM tricine pH 7.8 with an ÅKTA Purifier-10 from 
GE Life Sciences.  
 
Removal of the 2nd and labile metal from the active site was achieved by 3 step sequential 
dialysis. First, dialysis in 10L of 50mM tricine pH 7.8 containing 1mM 1,10-phenanthroline, 
second dialysis in 10L of 50mM tricine pH 7.8 containing 5mM ethylenediaminetetraacetic 
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acid (EDTA) and third dialysis was in 50mM de-metallated tricine pH 7.8 and each dialysis 
step was for about 8 to 12 hours at 4°C. Dialysis bags were from Spectrumlabs (Cat. # 
132655), approximate molecular weight cut-off of 6 to 8 KDa. Chelex-100 chelating ion 
exchange resins were from, Biorad. Purified DapE protein from S.enterica was analysed on 
SDS-PAGE and found a single band at a molecular weight of approximately 42 KDa. Protein 
concentrations were determined by using the Pierce BCA protein assay kit (Cat. # 23227, 
Thermo scientific). The yield of the purified DapE protein was about 1 mg/L of bacterial 
culture.  
 
Synthesis of SDAP. 
 
N-succinyl-L,L-diaminopimelic acid (SDAP) was synthesized in liquid phase through a 
standard coupling procedure between mono-tert-butyl succinate and enantiopure mono-tert-
butyl protected L,L-diaminopimelic dimethyl ester (protected DAP), using O-Benzotriazole-
N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) as coupling agent. The 
product of the coupling was then conveniently deprotected by standard cleavage of the 
protecting groups. DAP was previously synthesized according to published protocols via 
olefin cross-metathesis between enantiopure Boc-L-Allylglycine-OMe and Cbz-L-
Vinylglycine-OMe, in yields above 70%.13 
 
DapE enzyme activity assays. 
 
The kinetic assays were performed in triplicate in 50mM tricine pH 7.8 at 37°C, using the 
purified DapE-C6His to a final concentration of 100ng/100µl. The final substrate 
concentration of native substrate (SDAP) was 20mM in a reaction volume of 50 µl. DapE 
enzyme was pre-incubated with metals (0.2mM ZnCl2 & 0.5mM MnCl2 for native substrate 
and 1mM MnCl2 for the promiscuous substrate) at 37°C for an hour and then with the 
inhibitor for another 10 minutes. The reactions were initiated by adding substrate. The 
enzyme activity was measured by following the hydrolysis of the peptide bond of the 
substrates.11 Readings were taken for every 2 minutes for about 3 hours at UV230nm in UV 
transparent 96-well plates (Cat # 7.675 801, Greiner) using a TECAN Safire plate reader.  
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Results 
 
DapE from S.enterica typhimurium exhibits non-Michaelis-Menten behaviour both with 
native and promiscuous substrates. 
 
Kinetic analysis of DapE activity was found to exhibit non-Michaelis-Menten behavior, i.e. 
sigmoidal behaviour consistent with positive cooperativity, both when using the native 
substrate SDAP and the promiscuous substrate Asp-Leu dipeptide, (Figure 2). The Hill 
coefficients for SDAP and Asp-Leu were calculated as h = 3.17 and 2.61, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Positive cooperativity in both native and promiscuous activities of DapE, with Zn/Zn and 
Zn/Mn forms of the metalloenzyme, respectively. SDAP: succinyl diaminopimelic acid. For native 
desuccinylation activity, kcat = 528 s-1 and Hill coefficient = 3.17. For promiscuous dipeptidase activity, 
kcat = 383 s-1 and Hill coefficient = 2.61. All datapoints were measured in triplicate. 
 
Activation of native activity by a metal-selective promiscuous substrate 
 
The dipeptide Asp-Leu cannot be cleaved by the monometallated Zn/- or bimetallated Zn/Zn 
form of DapE, but is hydrolysed efficiently by the mixed Zn/Mn form of the enzyme. Since 
the native and promiscuous activities bind to the same active site, the substrates appear to 
behave as competitive inhibitors of each other.4  
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We also detected modest inhibition of the native activity with high concentrations (25mM) of 
Asp-Leu using the Zn/Zn isoform. Surprisingly, however, kinetic analysis of desuccinylation 
in presence of 25mM Asp-Leu revealed near-Michaelis-Menten behavior of the enzyme, as 
shown by a hyperbolic curve with h = 1.07 (Figure 3). As corresponds to a competitive 
inhibitor, the kcat for SDAP was not significantly affected, showing that saturating 
concentrations of substrate outcompete the inhibitor (kcat = 528 s-1 vs 578 s-1). Surprisingly, 
the shift from sigmoidal to hyperbolic behavior had the consequence of higher activity in 
presence of the competitive inhibitor at lower concentrations of substrate, below 
approximately 15mM SDAP (Figure 4). At higher substrate concentrations, Asp-Leu 
inhibition was modest, as expected from increasing saturation by the substrate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effect of Asp-Leu dipeptide on the native activity of Zn/Zn isoform of DapE. In presence of 
25mM of the dipeptide, hyperbolic, i.e. Michaelis-Menten, behaviour of the desuccinylation activity is 
observed, with Hill coefficient = 1.07. Note that Asp-Leu is not a substrate for the Zn/Zn form of the 
enzyme and that, as expected from a competitive inhibitor, the kcat is largely unaltered compared the 
non-inhibited enzyme (kcat = 570 s-1).  
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Figure 4. Relative activity of Zn/Zn isoform of DapE in presence of 0, 5 and 25 mM Asp-Leu dipeptide. 
In presence of 5 mM dipeptide, there is up to x 2.5 fold activation of desuccinylase activity at low 
substrate concentrations, at 25 mM dipeptide, activation is x4 to x6 fold at 5 mM substrate. In 
comparison, the dipeptide only exerts very marginal inhibitory effects even when present at high 
concentration and only observable to any extent at high substrate concentration. 
 
Activation of native activity by the competitive inhibitor L-captopril.  
 
L-captopril has been reported as a low-micromolar inhibitor of the H.influenzae form of DapE 
in vitro.7 Considering the high-conservation of H.influenzae and S.enterica DapE, it was 
expected that inhibitors like L-captopril would work for both forms of the enzyme.12 We 
confirmed this prediction by measuring inhibition by L-captopril of S.enterica DapE in vitro 
with an IC50 of approximately 30 µM, in presence of 20 mM SDAP as substrate. We then 
hypothesized that L-captopril, by virtue of binding to DapE competitively, would also be able 
to activate the enzyme at lower substrate concentrations,  in a fashion analogous as found for 
Asp-Leu; however, we expected that this activation would occur at much lower concentration 
of inhibitor compared with the poor inhibitor Asp-Leu, considering the low micromolar IC50 
for L-captopril. Indeed, carrying out kinetic analysis of desuccinylation at 30 µM L-captopril, 
at which half the enzyme sites would be expected to be bound, revealed Michaelis-Menten-
like hyperbolic behavior (h = 0.91), figure 5. The kcat of the enzyme that we measured was 
only modestly lower than the non-inhibited form compatible with a mechanism of competitive 
inhibition (kcat = 438 s-1 vs 528 s-1). Importantly, at 5 mM SDAP substrate, the enzyme was 
activated approximately 5-fold by L-captopril.  
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Figure 5. Effect of L-captopril on the native activity of Zn/Zn isoform of DapE. In presence of 30 µM L-
captopril, which was previously established as the IC50 in presence of 10 mM substrate, the kinetic 
curves become hyperbolic, i.e. following Michaelis-Menten behavior, with Hill coefficient = 0.91. Note 
that L-captopril is an inhibitor of the Zn/- and Zn/Zn isoforms of DapE, but not of the Zn/Mn isoform of 
the enzyme. As corresponds to competitive inhibition, the kcat is largely unaltered compared the non-
inhibited enzyme (kcat = 438 s-1 vs 528 s-1). 
 
Dimeric form of DapE 
 
Cooperativity in catalysis most commonly arises from structural rearrangements in oligomeric 
enzymes.14 Considering the high sequence similarity with the DapE of H.influenzae, which is 
reported as a dimer, a homology model of a DapE dimer from S.enterica typhimurium can be 
constructed with high confidence.15 Gel filtration-chromatography suggests a molecular 
weight for our recombinant DapE of 74 KDa (Figure 6), which is only slightly lower than 
theoretically expected for a dimer (84 KDa) and compatible with DapE being a stable 
homodimeric complex in solution. Our measurements coincide closely with the measured 
native molecular mass of the partially-isolated dipeptidase activity, retrospectively identified 
as DapE activity,4 which was reported as 70 kDa.16  
 
Introduction of mutations I236K and I236D by site-directed mutagenesis, which are predicted 
to disrupt dimerisation by introducing a buried charged residue in place of a hydrophobic 
contact, led to the inability of the expressed enzyme to complement DapE deficiency in 
S.enterica. This result is compatible with the notion that DapE dimerisation is necessary for 
activity. 
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Figure 6. Molecular weight estimation of DapE-His by size-exclusion chromatography on a GE 
Superdex 75 16/600. In (A) the UV absorbance at 280 nm [mAU] of conalbumin (75 kDa), albumin (66 
kDa), streptavidin (67 kDa), ovalbumin (45 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20 
kDa) and lysozyme (14 kDa) is plotted versus the elution volume [ml]. The DapE-His protein peak, in 
red, has a maximum at 51.3 ml of elution volume. In (B) the ratio of elution volume by void volume 
(44.5 ml) was plotted against the logarithm of the molecular mass [Da] for each protein with a known 
mass. The linear regression (dashed-line) equation calculated from this points was used to estimate 
DapE-His molecular weight from its Ve/Vo =1.15 ratio. The calculated molecular weight of DapE-His is 
74 kDa. Figure kindly provided by Dr. Stefan Nicolet. 
 
Structural comparisons of DapE 
 
To analyse potential substrate binding interactions of DapE, in particular the binding of the 
carboxyl of corresponding to the second amino acid in Asp-Leu, we compared the structure of 
DapE with those of two structurally-related enzymes crystallised with either an informative 
inhibitor or reaction product, i.e. carnosinase 2 in complex with the inhibitor bestatin 
(PDB:2zog)17 and a catalytic mutant of beta-alanine synthase in complex with reaction 
product beta-alanine (PDB:1r3n).18  
 
Superimposition of the structures of 3isz:A 2zog:A and 1r3n:A showed good alignment 
particularly at the catalytic domain with an RMSD of 1.59Å over 182 amino acids.19 
Although the dimerisation domains also conserve the same overall topology, despite lower 
sequence identity compared with the catalytic domains, the structural alignment does not 
cover the whole peptide chain chiefly because of different relative orientations of catalytic 
and dimerisation domains in the different structures.  
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Unlike the structure of DapE (3isz), which is in the putative “open conformation”, the 
structures of the catalytic mutant of beta-alanine and of carnosinase 2 are closed 
conformations, as corresponds to ligand-bound representing catalytically-competent enzymes. 
The superimposed structures suggest the functional conservation of the following substrate-
binding residues: 
 
• Interaction with substrate backbone-amide. The backbone carbonyl of G396 in beta-
alanine synthase shows a H-bonding to the product amine (arising from hydrolysis of 
the amide substrate). A similar interaction with the side-chain of the equivalent 
residue S417 is observed in carnosinase with its inhibitor bestatin and, finally, T325 in 
dapE was suggested potentially to have also this function. 
 
• Interaction with substrate carboxyl. 
o A conserved arginine, interacting within the same monomer that binds the 
substrate forms an ionic bridge with the substrate carboxyl (R343 in 
carnosinase and R322 in beta-alanine synthase). This position corresponds to 
R258 in DapE; however, in the case of DapE,it is likely that a substantial 
domain-movement around the putative hinge would be required to approach 
this residue closer to the active site. R258 is found structurally-close to R329, 
with which it forms the lining of a “pocket”; it is noteworthy that in one of the 
monomers of the de-metallated structure of DapE (3IC1), both of the side-
chains of these residues form an ionic interaction with a sulfate ion, which was 
suggested as a possibly mimicking a carboxylic group of the substrate.6 
 
o A conserved histidine, interacting with the opposite monomer that binds the 
substrate, forms a hydrogen-bond with the substrate carboxyl (H228 in 
carnosinase, which has been shown to be crucial for catalysis, and H262 in 
beta-alanine synthase). This position most likely corresponds to H194 in 
DapE, or possibly to the nearby-residue H199; however, H194 is not observed 
in the crystal structures of H.influenzae DapE due to low electron density 
around this loop, which is consistent with the notion that it is a flexible loop 
that can adopt different conformations.  
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o A conserved asparagine (N309 in beta-alanine synthase) or threonine (T330 in 
carnosinase), interacting with the opposite monomer that binds the substrate, 
form a hydrogen-bond with the substrate carboxyl. This position most likely 
corresponds either to N244 or N245 in DapE. Note that residues 241–245 were 
not modelled in chain B in the crystal structures of H.influenzae DapE due to 
disorder, again consistent with the notion that it is a flexible loop that can 
adopt different conformations. 
 
Recently, the crystal structure of the L-carbamoylase of Geobacillus stearothermophilus, 
another member of this M20 family of dimeric metallo-hydrolases, revealed unambiguously 
that dimerisation is necessary for the activity of this enzyme and pointed also to the 
involvement of the conserved residues discussed above for substrate binding.20 
 
SAXS analysis of DapE 
 
Attempts at detecting structural rearrangements of DapE upon L-captopril binding by small 
angle X-ray scattering did not reveal any significant difference between the bound and free 
form of the enzyme, (Figure 7); the curves, however, were also compatible with a dimeric 
structure in solution (Dr Stefan Nicolet, personal communication). However, we cannot rule 
out that such postulated domain movement does not occur during the catalytic reaction 
coordinate. 
 
	
  
Figure 7. Supplementation of 10µg/ml of the L-captopril inhibitor to the S. enterica DapE-His protein 
(2.0 mg/ml) does not change the SAXS intensity curve and therefore excludes any large-scale 
rearrangement of the protein. The momentum transfer s is defined as 4π sin(θ)/λ [nm-1], with the 
wavelength λ = 1.54Å. Figure kindly provided by Dr. Stefan Nicolet and Prof. Thomas Pfohl.  
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Note that, in carnosinase, ultracentrifugation analysis of the free enzyme or the enzyme bound 
to the bestatin inhibitor failed to find any conformational differences, despite the putative 
domain movements postulated upon substrate (or inhibitor) binding. One possible reason 
forwarded by the authors of that study was the possible small difference in axis ratio between 
both postulated forms. 
 
Discussion 
 
Evidence for cooperativity in S.enterica DapE 
 
Here we report on positive cooperativity in the kinetic behavior of DapE, a potential antibiotic 
target,3 as revealed by four lines of evidence: i) sigmoidal behavior in kinetic analyses with 
the native substrate SDAP, with the bimetallic Zn/Zn enzyme isoform; ii) sigmoidal behavior 
in kinetic analyses with the promiscuous substrate Asp-Leu, with the bimetallic Zn/Mn 
enzyme isoform; iii) recovery of Michaelis-Menten behavior upon addition of the weak 
competitive inhibitor Asp-Leu for the Zn/Zn isoform desuccinylase activity and iv) recovery 
of Michaelis-Menten behavior upon addition of low-micromolar concentrations of the 
competitive inhibitor L-captopril. To our knowledge, this study represents the first description 
of cooperative behavior of any DapE enzyme, which we conclude from detailed and 
comprehensive kinetic analysis of the enzyme from S.enterica. It will be interesting to explore 
whether other DapE enzymes also exhibit similar cooperative behavior; we suspect that 
cooperativity may be a property that, together with structure, function and inhibition profiles 
may also be conserved amongst isoforms of DapE. 
 
Hinge-domain movements and cooperativity in M20 metallohydrolases 
 
Although cooperativity may exist in monomeric enzymes through kinetic effects, 21 most 
cases of cooperativity in proteins (including enzymes) that have been reported are due to 
long-range conformational effects, as originally described for the classic experiments in 
haemoglobin.22	
  DapE is classified as belonging to the M20 family of metallohydrolases,23 in 
which hinge-domain movements have been reported or postulated on mechanistic grounds for 
many of its members. Domain movements are described for monomeric members like 
Sapep,24 PepV,25 auxin amidohydrolase,26 methionine aminopeptidase from E.coli 27 and the 
aminopeptidase of Aeromonas proteolytica28 as well as for its dimeric members like allantoate 
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amidohydrolase29 (which is activated allosterically by anion binding),30 carnosinase,17 yeast 
beta-alanine synthase,18,31 L-carbamoylase20,32,33 and human aminoacylase 1.34 PepD is 
structurally related to PepV, but exists as a dimer postulated to exhibit domain movements, 
although with a different spatial arrangement compared to other dimeric M20 dipeptidases 
like DapE.35 Finally, higher-order arrangements that may maintain hinge-like motions are also 
known and, for example, a metallohydrolase from S.aureus has been shown to be a tetramer36 
and the C.elegans beta-alanine synthase, which is an M20-family member with Michaelis-
Menten behavior, is a dodecamer.37 
 
Despite the many reports of domain-movements of M20 family-members, examples of 
cooperativity in these enzymes appear to be exceedingly rare, perhaps because this issue may 
have been underexplored. Human Liver beta-ureidopropionase (i.e. beta-alanine synthase) 
was reported to have a Hill coefficient of 2,38 which may be related to the formation of 
polymers.39 The rat liver beta-alanine synthase is also allosteric with Hill coefficient of 1.9 at 
low substrate concentrations; however, at higher substrate concentrations, Michaelis Menten-
kinetics were followed. Substrate binding also induced polymerization, to hexamers, which 
may be reason for cooperativity.40 However, the best characterized beta-alanine-synthase is 
from yeast, which structure shows open and closed conformations.18,31 Although for the yeast 
enzyme open and closed states appear to exist in equilibrium, the enzyme appears to have a 
very high KM (around 60mM) and there is no evidence of cooperativity.39 
 
Metalloenzymes of other families, such as insulysin of the M16 family, also show dimer-
dependent allostery involving large-domain hinge-motions. However, in the case of insulysin, 
binding of a peptide-activator occurs in a non-catalytic domain. This movement is proposed to 
be rate-limiting and both open and closed conformations appear to exist in solution for the 
unliganded enzyme.41 Mixed-dimers were used to abolish allostery.42 
 
Mechanism of cooperativity in DapE 
 
How does positive cooperativity arise in DapE of S.enterica? The enzyme appears to be a 
dimer in solution, as would be expected from structural homology with DapE from 
H.influenzae.6 By sequence and structural conservation of key residues predicted to bind the 
substrate, in particular R258, H194 and N244, which are predicted to bind the carboxyl at the 
second position of SDAP or Asp-dipeptides, it is reasonable to predict that the enzyme 
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requires large-domain movements during catalysis, which allow these key residues to 
approach the active site. In particular, two of these residues (H194 and N244) are predicted to 
interact with the substrate bound to the active site of the opposite monomer, thus providing a 
rational for the requirement of a dimeric enzyme. Such intermonomeric contacts could also 
provide a reasonable mechanism by which cooperativity between active sites could arise: 
binding of a substrate (or inhibitor) in one monomer may lead to a conformational change that 
facilitates binding to the other monomer. Large hinge-motions of domains may be rate-
limiting, as described for insulysin of the M16 family and it is possible that in DapE, ligand 
binding reduces the extent of such motions. Alternatively or additionally, a “closed” 
conformation on one monomer may lower the KM or increase kcat of the other monomer 
through electrostatic effects, for example. 
 
It is possible that DapE in solution exists as an equilibrium of both open and closed 
conformations, as has also been suggested for insulysin.41 In carnosinase, despite the 
postulated existence of open and closed forms for unliganded or liganded enzyme, 
ultracentrifugation analysis failed to detect any large conformational isoforms.17 Our gel 
filtration analysis showed a single peak of enzyme eluting at a position compatible with a 
dimer and we failed to detect differences between ligand-free and ligand-bound by SAXS. 
Further structural and mutational analyses will be necessary to elucidate the exact details of 
how positive cooperativity is achieved in DapE. 
 
Function of cooperativity in DapE 
 
An additional question of interest is why does cooperativity exist in DapE at all? 
Cooperativity may offer a facile way to adapt affinity in evolution and arises often through 
formation of dimers or oligomers.43,44 Thus, positive cooperativity facilitates an “all or 
nothing behavior”. Although the concentrations of SDAP occurring in vivo are difficult to 
estimate, the presence of cooperativity at the low-mM range of substrate suggests strongly 
that this phenomenon is of physiological relevance for DapE. It has also been argued that 
cooperativity may allow kinetic control at the expense of maximal efficiency.45 For DapE, 
one could speculate that there is a suboptimal activity of the enzyme under normal conditions, 
because physiological concentrations of substrate apparently would not lead to maximal 
possible activation; instead, one could imagine the first monomer being as catalytically active 
as the second even at very low substrate concentrations. Care must be taken with this 
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argument, because it is conceivable that there is no accessible way of reaching such high 
efficiency except in the form of cooperativity by dimerisation. However, assuming that one 
could conceive a very active monomer or very active independent monomers in a dimer, i.e. 
that DapE could be more “catalytically perfect” (defined as maximum possible kcat/KM) in the 
absence of cooperativity, then less enzyme would be required to maintain the same flow 
through the pathway, thus providing potential energetic benefits, i.e.  in the form of lowered 
requirement of protein synthesis. Consequently, if positive cooperativity is the product of 
evolution and more efficiency could be achieved at low substrate concentration, then 
whatever advantages this phenomenon confers would be a trade-off for low efficiency. 
Therefore, what advantages could cooperative behavior confer to DapE?  
 
Conceivably, cooperativity could be a mechanism for specificity, maximizing activity with 
useful substrates whilst minimizing unwanted catalytic transformation. However, the K50 both 
for the native substrate SDAP and the promiscuous substrate Asp-Leu appear to be similar, at 
around 15mM. Consequently, little selectivity appears to be gained, unless the normally 
available concentration of SDAP would exceed that of dipeptides like Asp-Leu, which seems 
unlikely. A possibly advantageous scenario for selectivity could be envisaged with large 
fluctuations of substrate, where the “activation” levels of the unwanted substrate, presumably 
an unwanted non-specific peptidase activity, would seldom be reached. 
 
However, one may speculate about an alternative benefit for cooperativity, namely to protect 
against inhibition of this essential enzyme activity, as follows: DapE is a crucial activity for a 
bacterial cell; endogenous competitive inhibitors of the enzyme, such as aspartate dipeptides, 
are likely to exist physiologically and it is very likely that competing organisms could easily 
synthesise competitive inhibitors of DapE with potential antimicrobial activity; to survice, the 
bacterial cell would need to respond by increasing DapE expression, which is a slow process 
that may endanger survival; instead, it would be of benefit to have an “excess” amount of 
DapE ready for immediate release in case of necessity, e.g. in presence of an inhibitor; 
however, considering the potential toxic promiscuous activity of the enzyme as a dipeptidase, 
activation should be only when necessary and easily reversible. It is obvious that positive 
cooperativity provides a facile solution to this potential threat, at a presumably acceptable 
energetic and evolutionary cost.  
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Implications for cooperativity in drug design 
 
In vivo, cooperativity may be a buffering system to prevent inhibition by internal promiscuous 
binders if they sporadically become abundant, such as Asp-Leu or by external inhibitors. The 
implications for inhibitor design are of relevance: a competitive inhibitor will only be really 
effective when it has extremely strong affinity for the enzyme and inhibits in near-
stoichiometric amounts. The reason for these two requirement is that inhibiting the enzyme 
only partially and leaving many sites unbound would be insufficient, because the remaining 
sites would remain very active, thereby compensating for the inhibition. The failure of L-
captopril to exert DapE-targetted antimicrobial activity may be due in part to incomplete 
targeting of all available cellular enzyme, thereby leading to unaffected overall cell growth. 
Note that this argument would not hold for monomeric enzymes exhibiting cooperative 
behavior from kinetic effects alone, because binding to the active site would be sufficient to 
prevent activation. Consequently, the monomeric form of the predicted SDAP desuccinylase 
from S.aureus, SaPEP,24,46 may provide an easier  target for inhibition. For the dimeric 
S.enterica DapE, alternatives to finding useful competitive inhibitors include: i) exploring 
other types of inhibitors that do not lead to cooperative activation (e.g. uncompetitive, non-
competitive inhibitors); ii) inhibitors that simultaneously target both monomers of the same 
dimer; iii) inhibitors that destroy enzyme activity in other ways, such as preventing 
dimerisation or iv) inhibitors of activation itself, for which an atomic description of this 
allosteric phenomenon would be very helpful. 
 
Cooperativity also poses additional practical challenges for screening for inhibitors in vitro. 
Typical screening conditions are carried out at non-saturating concentration of substrate, not 
just for cost-saving reasons but also because finding a competitive inhibitor at high substrate 
concentrations is intrinsically difficult, due to inhibitors being easily “outcompeted”. 
However, in the case of positive cooperativity, finding an inhibitor at lower substrate 
concentrations is also difficult, because molecules that bind effectively to the active site may 
not be identified at all because they do not change the read-out of the assay or even be 
detected as “activators” in vitro. Consequently, it would be difficult to find lead-compounds 
for further improvement, which would otherwise be found easily in the absence of 
cooperative behavior. 
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Conclusions 
 
In summary, we describe for the first time positive cooperativity in S.enterica DapE, which 
may arise from its dimeric structure and postulated large domain movements that cause the 
interaction of one monomer with the substrate bound to the active site of the opposite 
monomer. Cooperativity appears to ensure that even when inhibiting species are bound, the 
overall steady-state of the enzyme remains relatively unaffected and, therefore, may be an 
evolutionary adaptation to protect the function of this essential enzyme in many bacteria. The 
cooperative behavior of DapE poses practical challenges for the development of drugs against 
this potential antibiotic target. 
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CHAPTER 5 
 
Facile functional recombination of mutations  
by pairwise heteroduplex formation by PCR  
in experimental protein evolution 
 
Abstract 
 
Genetic recombination is a ubiquitous general strategy for generating sequence diversity. 
Sexual-reproduction appears to have evolved as a consequence of selective advantage of 
genetic recombination, although the exact cost-benefit of having males in a population are 
still a matter of debate.1 Recombination has two main advantages: i) rapid testing of 
combinations of individual mutations that are known to have been previously selected, 
thereby exploring functionally-enriched sequence-space and ii) removal of deleterious 
mutations, thus preventing the potential slow decline in fitness of asexual populations that has 
become known as Muller’s ratchet.2 Directed evolution experiments commonly use in vitro 
recombination to improve the property of the protein being evolved, as pioneered by Stemmer 
in so-called “sexual PCR”.3,4 Of the plethora of genetic recombination techniques available to 
the experimenter,5-7 a facile and in our view underexploited method is in vivo repair of 
heteroduplexes.8,9 Here, we establish a platform for laboratory evolution of an enzyme, the 
bacterial amide hydrolase DapE,10,11 using novel protocols for heteroduplex-formation for 
pairwise recombination of mutations in bacteria. 
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Introduction 
 
There are many reports of sequence diversity arising as an artefact of PCR and methods to 
minimise them, for example recombination arising from in vivo repair of heteroduplexes. In 
E.coli, such artefactual recombination in vivo is thought to occur through the host’s nick-
directed mismatch repair system MutHLS, known as “long-patch” system.12,13 However, such 
a repair system may also be exploited to generate useful diversity in directed evolution 
experiments.8,9 Here we present a novel PCR based protocols for facile recombination in 
laboratory evolution experiments.  
 
Materials and methods 
 
PCR method A 
pCM655 plasmid11 containing variants of dapE were PCR co-amplified by using one or more 
templates in a single pot PCR using the primers F & R pCM655 for 25 cycles at 60°C 
annealing temperature using Mutazyme II polymerase. The resulting PCR product was cloned 
into empty pCM plasmid and then transformed into S.enterica electrocompetent TN5911 cells 
lacking dapE gene and platted on AMP-LB plates containing DAP (no selection pressure) and 
without DAP supplementation (selection for the DapE enzyme activity). 
 
PCR method B 
pCM655-dapE plasmids harbouring stop codons at various positions and tested to be non-
functional for DapE activity were PCR co-amplified by using overlapping primers 
downstream to the gene. PCR reaction of 35 cycles was done using the following primers  
5’ CGTGGGCCGTGCACCTTAAGCTTAAGG 3’ and  
5’ GCACGGCCCACGTGGCCACTAGTACTTC 3’ at 50°C annealing temperature using 
TurboPfu polymerase. The resulting PCR product was transformed in S.enterica 
electrocompetent TN5911 cells lacking dapE gene and platted on AMP-LB plates containing 
DAP (no selection) or not (DapE activity required). 
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Figure	
   1.	
  Overview	
  of	
   recombination	
   protocols.	
   The	
   first	
  method	
   (A)	
   implies	
   co-­‐amplification	
   by	
   PCR	
   of	
   two	
  
dapE	
   gene	
   variants	
   containing	
   different	
   mutations	
   depicted	
   in	
   red	
   and	
   blue;	
   digestion	
   with	
   the	
   restriction	
  
enzyme	
  HindIII	
  and	
  cloning	
  into	
  the	
  pCM655	
  vector11	
  followed	
  by	
  transformation	
  into	
  S.enterica.	
  The	
  resulting	
  
sequenced	
  plasmids	
  isolated	
  from	
  single	
  colony	
  clones	
  present	
  recombination	
  events.	
  The	
  second	
  method	
  (B)	
  
consist	
   in	
  co-­‐amplifying	
  the	
  whole	
  plasmids	
  by	
  PCR	
  using	
  primers	
  downstream	
  to	
  the	
  dapE	
  gene,	
  followed	
  by	
  
transformation	
  of	
   the	
  PCR	
  product	
   into	
  S.enterica.	
   The	
   same	
   type	
  of	
   recombination	
  as	
  with	
  method	
  A	
  were	
  
observed.	
  Figure	
  courtesy,	
  Dr.	
  Stefan	
  Nicolet.	
  
	
  
Results 
From the PCR method A (Figure 1), 9 single pot PCRs were carried out, in which each PCR 
had two templates consisting of DapE variants with defined point mutations. From the 9 
randomisations 181 variants (i.e. 20 variants from each randomisation) were sequenced to 
identify the number of recombination events and the distances between the recombinations. 
From the PCR method B (Figure 1), 11 PCR mixes of two different plasmids were carried 
out. A total of 104 colonies were found to grow in LB-agar AMP plates supplemented with 
DAP. Only 3 wt colonies grew in LB-agar + AMP plates (2.9% of recombinations yielding 
back DapE wild-type activity). 
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Figure	
   2.	
   Distance	
   in	
   amino	
   acids	
   (codons)	
   between	
   possible	
   DNA	
   recombination	
   events	
   plotted	
   with	
  
corresponding	
  frequency	
  of	
  recombination.	
  The	
  frequency	
  is	
  defined	
  by	
  the	
  ratio	
  of	
  observed	
  recombinations	
  
by	
   the	
   total	
   number	
   of	
   sequenced	
   genes.	
   The	
   data	
   suggest	
   that	
   there	
   are	
   very	
   few	
   recombinations	
   at	
  
mutations	
   that	
   are	
   a	
   short-­‐distance	
   apart,	
   whereas	
   the	
   few	
   cases	
   observed	
   of	
   neighbouring	
   mutations	
  
separated	
  by	
  a	
  large	
  distance	
  recombine	
  more	
  frequently.	
  However,	
  	
  frequency	
  of	
  recombination	
  shows	
  a	
  lot	
  
of	
  variability.	
  The	
  frequency	
  of	
  events	
  never	
  exceeded	
  50%,	
  as	
  predicted	
  by	
  probabilities	
  (25%	
  template	
  A,	
  50%	
  
template	
  A+B,	
  25%	
  template	
  B).	
  Figure	
  courtesy,	
  Dr.	
  Stefan	
  Nicolet.  
 
Figure	
   3.	
   Plot	
   of	
   all	
   the	
   frequencies	
   of	
   observed	
   recombination	
   events,	
   where	
   these	
   are	
   possible,	
   versus	
  
distance	
  in	
  amino	
  acids.	
  The	
  data	
  suggest	
  a	
  higher	
  frequency	
  of	
  recombination	
  with	
  larger	
  distance,	
  although	
  
only	
   the	
   smallest	
   possible	
   distances	
   of	
   feasible	
   recombinations	
  were	
   considered.	
   Figure	
   courtesy,	
  Dr.	
   Stefan	
  
Nicolet.	
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Discussion and conclusions 
The method of heteroduplex formation and repair in vivo reported here mimics sexual 
recombination in that “shuffling” only occurs pairwise, i.e. between two strands each arising 
from their corresponding parental templates, regardless of the diversity of sequences in the 
original reaction. In classical “shuffling” protocols, where typically parental genes are 
fragmented and then reassembled by PCR, extreme sequence divergence can arise rapidly as a 
consequence of offspring from multiple parents. In contrast, with heteroduplex recombination 
in vivo only mixes of two variants are chosen, regardless of the initial diversity: consequently, 
extreme sequence divergence is minimised and only near-neighbours are explored. This 
property of heteroduplex recombination may be a distinct advantage, particularly where only 
relatively small libraries are explored, for example due to limited transformation efficiency. 
 
We have simplified the protocols previously reported 8,9 in two ways: 
 
A. For ligation of heteroduplex inserts, we implemented a one-pot PCR, in which two or 
more templates can be mixed, i.e. the inserts do not need to be amplified separately. 
Moreover, we also implemented the use of a mutazyme polymerase, which allowed 
incorporation of random mutations at this step at the same time that pairwise 
recombination could occur, thus more closely mimicking diversification by sexual 
reproduction and minimising parental templates. Finally, we explored the number and 
distance of recombinations comprehensively, using larger mixed-libraries than 
previously reported (e.g. previously, no recombination nearer than 24 bp was tested, 
whereas we explored possible recombinations arising “randomly” in our selected 
variants). 
 
B. For whole-plasmid heteroduplex construction, we implemented a one-step PCR 
method using partial overlapping primers.14 The novel protocol has several advantages 
including: i) the reaction is “one-pot”, rather than having to treat plasmids separately 
before re-annealing; ii) it circumvents the requirement of restriction digestion 
altogether. 
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In both protocols above, the limitation of primer-availability at the end of PCR reaction, 
probably ensures the enrichment of heteroduplexes;12 however, we suggest that an additional 
cycle of re-annealing without further extension may facilitate heteroduplex formation. In all 
cases, parental homoduplexes may be present, although these can be also minimised by 
statistical dilution, simply by incorporating many diverse templates in the one-pot PCR 
mixture. Finally, a limitation of these protocols is that hybrid duplexes may not form well 
with only-distantly-related sequences that may pair-poorly into defined double-helixes, thus 
limiting drastically transformation and recombination efficiency. However, the protocol does 
have hitherto under-exploited and great potential for facile and truly biomimetic “sexual 
evolution”. In summary, the data suggest that there are very few recombinations at mutations 
short-distances apart, whereas the fewer cases observed of neighbouring mutations separated 
by a large distance recombine more frequently (Figure 2). However, frequency of 
recombination shows a lot of variability (Figures 2 & 3). 
 
Perspectives 
 
It may be relevant to assess whether such recombination events also occur in E.coli in vivo. 
Further, we plan to investigate if recombination events can also occur with more distantly-
related genes, by PCR co-amplifying E.coli and S.enterica dapE genes sharing 94.4% identity 
at the protein level and 83.3% identity at the DNA level. 
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 CHAPTER 6 
 
A Mechanistic Proposal for the Curious Metal-Dependent 
Substrate Promiscuity of the Bacterial Amide-Hydrolase DapE  
 
 
Abstract 
 
DapE (N-succinyl-L,L-diaminopimelic acid desuccinylase) is an essential metalloenzyme for 
most Gram-negative and many Gram-positive bacteria, which has been proposed as a good 
target for antibiotic development. Apart from its native desuccinylase activity, the enzyme 
exhibits Mn-dependent promiscuous aspartyl dipeptidase activity both in vitro and in vivo. 
Toward the development of novel DapE-targeting compounds, here we sought to explore the 
mechanism of such curious metal-dependent promiscuity and substrate selectivity, by 
exploring a range of compounds as potential substrates or inhibitors. We propose a model of 
substrate or inhibitor binding that qualitatively explains metal-selective activities of the 
enzyme. We conclude that the substrate binds in a different orientation to what has been 
hitherto accepted and also provide insights for the development of novel inhibitors.  
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Introduction 
 
Emergency against antimicrobial resistance   
 
Antimicrobial resistance (AMR) arises as a consequence of the use and misuse of 
antimicrobial medicines and develops when a microorganism mutates or acquires a resistance 
gene.1 Infections caused by resistant microorganisms often fail to respond to the standard 
treatment, resulting in prolonged illness and greater risk of death. For example, about 440 000 
new cases of multidrug-resistant tuberculosis emerge annually, causing at least 150 000 
deaths. Extensively drug-resistant tuberculosis  has been reported in 64 countries to date.2 
  
An effective strategy against AMR doesn’t require only a global response in terms of policies 
and practices for the prevention and control of infections, but also the finding of new 
antimicrobials. While antimicrobial resistance is rapidly spreading, few pharmaceutical 
companies are still researching and developing new antibiotics. In 2004, 506 drugs in 
development by 15 large pharmaceutical companies and seven major biotechnology 
companies, only six were antibiotics. Approval of new antibacterial agents by the United 
States Food and Drug Administration decreased by 56% between 1998 and 2002. In 2008, a 
study of antibiotic development involving small firms as well as large pharmaceutical 
companies revealed that only 15 of 167 antibiotics under development had a new mechanism 
of action. If the current trend continues, before long there may not be effective antimicrobials 
with which to treat patients with serious infections.3 
 
It is known that inhibitors of cell wall biosynthesis (like β-lactams, for example) show a very 
strong antibiotic activity and that enzymes involved in cell-wall synthesis are similar in 
structure and function, so that certain antibiotics can kill a broad range of different bacterial 
species.4 Moreover, essential amino acids are synthesised only in plants and microorganisms, 
but not in humans or other higher organisms. For example, lysine is synthesized in E.coli 
from aspartate by an 11-step path which offers many potential antimicrobial enzyme targets.5 
Lysine is required in protein synthesis and in the formation of the peptidoglycan layer of 
Gram-positive bacterial cell walls. Meso-DAP, an intermediate in this pathway, is also an 
essential component of the peptidoglycan cell wall for Gram-negative bacteria.6 Since lysine 
is an essential amino acid and is not synthesized by humans, it must be ingested. However, 
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most bacteria, plants, and algae synthesize lysine and m-DAP from aspartic acid through three 
related pathways that diverge after the production of L-tetrahydrodipicolinate (Figure 1).5  
 
The primary biosynthetic pathway in bacteria, used by almost Gram-negative and many 
Gram-positive bacteria is the succinylase pathway.7,8 The dehydrogenase pathway forms m-
DAP directly from L-tetrahydrodipicolinate, but this is a high-energy transformation and is 
limited to only a few Bacillus species. The acetylase pathway is also a minor biosynthetic 
pathway for m-DAP production and is also limited to only a few Bacillus species. 
 
 
Figure 1. Pathways to lysine biosynthesis. Graphics courtesy, Dr. Gaetano Angelici. 
 
DapE is a good target for new potential antibiotics 
 
One of the enzymes in the succinylase pathway, the dapE encoded N-succinyl-L,L-
diaminopimelic acid desuccinylase (DapE), is a Zn(II)-containing metallohydrolase. More 
specifically, DapE catalyzes the hydrolysis of N-succynyl-L,L-diaminopimelic acid (SDAP), 
forming L,L-diaminopimelic acid and succinate (Scheme 1). DapE deletion is lethal to 
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Helicobacter pylori and Mycobacterium smegmatis.9 Therefore, DapE enzymes appear to be 
essential for cell growth and proliferation and are part of a biosynthetic pathway that is the 
only source of lysine in most bacteria. Since there are no similar biosynthetic pathways in 
mammals, DapE enzymes appear to be potential targets for inhibitors that may possess 
antimicrobial activity, i.e. inhibitors of enzymes in the mDAP/Lysine pathway could provide 
selective toxicity against bacteria whilst  potentially having no side-effects on humans. 
 
O2C NH
O
CO2
CO2
NH3
DapE
CO2
CO2
NH3
H3N
O2C
CO2 +
N-succinyl-L,L-diaminopimelic acid
(SDAP)
L,L-diaminopimelic acidsuccinate
 
Scheme 1. Hydrolysis reaction of SDAP catalyzed by DapE 
 
Structure of DapE and proposed mechanism 
 
The high-resolution crystal structure of the DapE from Haemophilus influenza has been 
recently reported by Nocek et al.10 showing that DapE includes two domains: a dimerization 
domain and a catalytic domain. The active site of the enzyme can contain either two or one 
zinc ions (Zn2+) of which only one is tightly bound to the active site. The core of the catalytic 
domain consists of an eight-stranded twisted β-sheet that is sandwiched between seven α-
helices. The location and the architecture of the active site in Zn/Zn_DapE are strikingly 
similar to the dinuclear active sites of CPG211 and AAP. The two zinc ions in Zn/Zn_DapE 
are 3.36 Å apart compared with 3.45 Å for AAP and 3.25 Å for CPG2.12 Like AAP and 
CPG2, each of the zinc ions in Zn/Zn_DapE adopts a distorted tetrahedral or trigonal 
bipyramidal (TBP) geometry with the Nɛ nitrogen of His67 for Zn1 and H349 for Zn2 along 
with a bridging water/hydroxide oxygen atom making up the axial positions of a potential 
TBP geometry. Identical with CPG2 and AAP, each zinc ion is coordinated by one imidazole 
group (H67 for Zn1 and H349 for Zn2) and the carboxylate oxygens of E163 (OE1 and the 
dangling oxygen OE2) for Zn1 and E135 for Zn2 (OE1 and the dangling oxygen OE2). Both 
zinc ions are bridged by D100 and a water/hydroxide (Figure 2). 
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Based on the proposed mechanism for AAP13,14 and on the crystal structure, Nocek at al. 
proposed a mechanism for both the mono-Zn and di-Zn (Scheme 2) forms of DapE. The first 
step in catalysis for DapE's is likely recognition of the L,L-SDAP side chain by the smile-
shaped cavity adjacent to the Zn1 site. Next, the peptide carbonyl oxygen of L,L-SDAP 
coordinates to Zn1, expanding its coordination number from four to five, activating the 
substrate for nucleophilic attack. Deprotonation of the metal-bound water molecule by E134 
to form a nucleophilic hydroxide moiety is consistent with the postulated pKa of the zinc-
bound water molecule.8 Once the zinc-bound hydroxide is formed, it can attack the activated 
carbonyl carbon of the substrate, forming an η-1-µ-transition-state complex.  Once the 
products are released, a water molecule bridging the two metal ions is replaced. In the 
presence of a dinuclear site, the second metal ion likely coordinates either the peptide 
carbonyl oxygen in a bridging fashion or a carboxylate side chain of the substrate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Structure of DapE (Haemophilus Influenzae) proposed by Nocek et al. and enlargement of 
the corresponding active site. Graphics courtesy, Dr. Stefan Nicolet. 
 
Summarising the proposed mechanism of Nocek et al.: Zn1 is thought to coordinate the 
carbonyl group of the peptidic bond and takes part to the hydrolysis reaction by coordinating 
water (or hydroxide), whereas Zn2 has the likely function of coordinating the carboxylic acid 
of the second amino acid (Scheme 2).10 
 
His349 
Asp100 
His67 
Glu163 
Glu163 
Glu134 
Zn 
Catalytic Active Site 
Dimerization 
Domain 
Catalytic 
Domain 
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Scheme 2. Reaction mechanism proposed by Nocek et al..10 Graphics courtesy, Dr. Gaetano Angelici. 
 
Metal-dependent promiscuity of DapE, consequences for potential antibiotics and 
evolutionary considerations 
 
It is currently unclear whether the mechanism for substrate binding proposed by Nocek et al.10 
based on the X-Ray structure of DapE is correct. Crystal structures often provide an 
insufficient picture to understand function:15 a relevant example where crystal structures do 
not explain why an enzyme fails to be catalytically active is provided by the metallohydrolase 
carnosinase CN2, which  requires Mn2+ exclusively for its enzyme reaction; however the fine 
structures of the metal-binding sites in the Mn2+ and Zn2+ complexes with a transition-state 
analogue/inhibitor are highly similar.16 Consequently, there is no obvious reason why the Zn-
metalloisoform should fail to be catalytically-active or what genetic changes would be 
required to hydrolyse the substrate.  
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DapE presents also a promiscuous dipeptidase activity. In the presence of manganese ions 
(Mn2+), DapE is able to cleave the dipeptide Asp-Leu (Scheme 3).17   
 
O
O
H3N
O
H
N
O
O DapE
Mn2+
O
O
H3N
O
O
H3N O
O
H-Asp-Leu-OH Aspartate Leucine
+
 
Scheme 3. Metal-Dependant Substrate Promiscuity of DapE in presence of Mn2+. Hydrolysis of 
dipeptide H-Asp-Leu-OH. 
 
It is perhaps not surprising that DapE can act as a peptidase as well as a desuccinylase, being 
both amide hydrolysis reactions; moreover, aspartate can be viewed as a structural analogues 
of succinate, differing only by the presence of a charged alpha amino group. However, among 
a number of structural analogues of SDAP, Zn2-activated DapE hydrolyzed only N-succinyl-
L,D-diaminopimelate at a rate comparable to that of SDAP, and most other succinylated 
analogues of L,L-DAP were not hydrolyzed at all. DapE has therefore been considered a 
highly specific enzyme.18 Therefore, it was surprising that, for its best peptide substrates, the 
enzymatic efficiency of DapE was almost as great as that for its normal substrate, SDAP.17 
 
The curious Mn-dependent dipeptidase activity of DapE is a unique and mysterious example 
of metal-mediated substrate promiscuity. We were thus interested in exploring the enzymatic 
mechanism as well as in designing potential inhibitors and antibiotics targeting the metal 
active site. A superficial  interpretation of the mechanism or the assumption that the 
metalloisoform studied in vitro will be the same metallo-isoform as is targeted in vivo could 
indeed lead to the failure of a potential drug. 
 
For example, L-captopril, which has been shown to exhibit very promising inhibitory activity 
in vitro against DapE, does not target DapE in bacteria effectively.19 We previously 
demonstrated that L-captopril targets only the Zn2+-metallo-isoform of the enzyme, whereas 
the Mn2+-enzyme, which is also a physiologically-relevant isoform in bacteria, is not inhibited 
(Table 1). This finding provides a rational for the failure of this promising lead-compound to 
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exhibit any significant antibiotic activity in bacteria and underlines the importance of 
addressing metallo-isoform heterogeneity in drug design. Moreover, to our knowledge, this is 
the first example of metallo-isoform heterogeneity in vivo that provides an evolutionary 
advantage to bacteria upon drug-challenge. 
 
 Zn1/-- Zn1/Zn2 Zn1/Mn2 
Native activity 
(SDAP) 
kcat = 300 s-­‐1 kcat = 700 s-­‐1 kcat = 1100 s-­‐1 
Promiscuos activity  
(Asp-Leu) 
Kcat = 0 Kcat = 0 kcat = 500 s-­‐1 
Inhibiton of Native 
activity by L-Captopril 
IC50 = 10µM IC50 = 28µM 
No inhibition  
even at 1mM L-captopril 
 
Table 1. Native and promiscuous activities of different metallo isoforms of DapE. Inhibition of DapE 
native activity by L-captpril. 
 
It is widely accepted that many enzymes evolved from pre-existing enzymes via gene 
duplication . Cumulative evidence suggests that nature has used common binding sites and 
common mechanistic features to catalyze the analogous reactions with different substrates 
and, further, has used common mechanistic features to catalyze different reactions. 
Particularly, the presence of different metal ions in metalloenzymes can maintain the overall 
structure of the active site, but provides alternative coordination interactions with substrates 
and inhibitors. It has already been pointed out that non-strict metal incorporation can be used 
as a facile way to create catalytic diversity.20 
 
Methods 
 
Expression and purification of recombinant DapE 
Expression and purification of His-tagged DapE from S.enterica (DapE-C6His) was carried 
out as previously described in Chapter 3. 
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DapE kinetic assays 
 
The enzymatic assays were carried out in 50 mM tricine pH 7.8 at 37°C, using the purified 
DapE-C6His to a final concentration of 1 ng/µl with a reaction volume of 50 µl or 100 µl. 
Initially the DapE enzyme was pre-incubated with metals (0.2 mM ZnCl2 & 0.5 mM MnCl2 
for native substrate) at 37°C for an hour and then, if appropriate, with the inhibitor for another 
10 minutes. In all cases the reactions were initiated by adding substrate. The enzymatic 
reaction was followed by measuring the hydrolysis of the peptide bond of substrate every 2 
minutes for about 3 hours at UV230nm by using UV transparent 96-well plates (Cat # 7.675 
801, Greiner) in a TECAN Safire plate reader. 
  
Synthesis 
 
All dipeptides (or analogues) were synthesized in liquid phase through a standard coupling 
procedures from commercially available compounds using O-Benzotriazole-N,N,N’,N’-
tetramethyl-uronium-hexafluoro-phosphate (HBTU) as coupling agent. The product of the 
coupling was then conveniently deprotected by standard cleavage of the protecting groups. 
For DAP derivatives, protected DAP was previously synthesized according to published 
protocols via olefin cross-metathesis between enantiopure Boc-L-Allylglycine-OMe and Cbz-
L-Vinylglycine-OMe, in yields above 70%.21  
 
Results 
 
We screened before the native and promiscuous activity for the different metalloisoforms of 
DapE, finding that the presence of Mn2+ relatively increased the native activity compared to 
Zn2+ or no metal.  
 
As expected, only the Mn2+ metalloisoform showed the promiscuous peptidase activity, as 
shown by hydrolysis of the dipeptide Asp-Leu, (Table 1). In order to evaluate the binding 
mode of the native substrate SDAP and of other possible promiscuous substrates, we begun 
by designing several substrate-derivatives.  
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Influence of the second amino acid on succinate containing peptides on DapE 
metalloisoforms 
 
In a first series, only the succinyl moiety was maintained (compounds 1-4, Figure 3) to 
evaluate the influence of the second amino acid on the activity of the three metalloisoforms of 
DapE. The diamino pimelic acid moiety (DAP) was substituted by the close analogue lysine, 
Leucine or ε-Lysine; we failed to detect activity with the latter, indicating that the interaction 
of the carboxylic acid in α of the second amino acid is essential in the active site. The values 
of the kinetic constants Kcat for the different metalloisoforms seems to suggest a increased 
activity in presence of manganese. 
 
O
NH
OH
O
H2N OH
O
HO
O
O
NH
O
NH
OH
O
HO
O
NH
O
OH
O
HO
O
H2N
Suc-DAP (1) Suc-Leu (2) Suc-Lys (3) Suc-ε-Lys (4)
H2N OH
O
HO
O
 
Figure 3. Native  substrate (Suc-DAP) of DapE and its analogues.  
 
Substrate Zn/--  Kcat (s-1) Zn/Zn  Kcat (s-1) Zn/Mn  Kcat (s-1) 
Suc-DAP 300 700 1100 
Suc-Lys NT NT NT 
Suc-ε-Lys ND ND ND 
Suc-Leu ND 80 168 
 
Table 2. kcat values of different metallo isoforms of DapE  for native substrate and for the substrate 
analogues. ND is not detectable. NT is not tested. 
 
Influence of the second amino acid on aspartate containing peptides on DapE 
metalloisoform 
 
We also evaluated the influence of the second amino acid on the three metalloisoforms of 
DapE, whilst maintaining Asp in the first position (Figure 4).  
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Figure 4. Promiscuous substrate (Asp-Leu) of DapE and its analogues. 
 
 
Substrate Zn/--  Kcat (s-1) Zn/Zn  Kcat (s-1) Zn/Mn  Kcat (s-1) 
Asp-Leu ND ND 500 
Asp-DAP ND ND 20 
Asp-Asn ND ND 538 
Asp-Lys NT NT NT 
Asp-ε-Lys ND ND ND 
Asp-Ser ND ND 927 
Asp-Pro ND ND ND 
Asp-iPentyl ND ND ND 
 
Table 3. kcat values of different metallo isoforms of DapE  for promiscuous substrate and for the 
substrate analogues. ND is not detectable. NT is not tested. 
 
None of the molecules tested in Figure 4 were active for the mono-Zinc and di-Zinc DapE,  
whereas compounds 5, 6, 7, 8 and 10 were all hydrolyzed to different extents in presence of 
manganese, consistent with the essential role of this metal for the coordination of an 
aspartate-containing dipeptide and with potential bidentate coordination (Scheme 5).  Notice 
how Asp-ε-Lys (9) and Asp-iPentyl (12) didn’t hydrolize at all, in accordance with the 
already observed crucial role of the carboxyl acid in α of the second amino acid. Asp-Pro (11) 
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was not a substrate for the promiscuous activity of DapE, as previously reported,17 probably 
for the presence of the more constrained proline which requires specific prolinase enzyme for 
hydrolysis. Prolidase and prolinase are thought to be the only known enzymes capable of 
degrading proline-containing dipeptides to produce free proline as a product.22 
 
Moreover, Asp-DAP, more similar to the native substrate and therefore, probably more rich of 
interactions, shows a really low Kcat, suggesting that it could be a good competitive inhibitor. 
 
Spatial configuration of aspartate isomers and space availability in the catalytic cavity 
for leucine containing peptides 
 
Considering the proven secondary role of the second amino acid (as long the α carboxylic 
moiety remains) we synthesized and tested a series of Leu containing peptides at this position 
to test the effect of modifications at the first position (Figure 5), i.e. changing the 
configuration and the isomeric structure of aspartate, in order to better understand the nature 
of the putative bidentate coordination. Aspartate was also substituted with glutamic acid to 
explore the effect of chain length and to verify the space availability in the active site.  
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Figure 5. Analogues Promiscuous substrate (Asp-Leu) of DapE. 
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Substrate Zn/--  Kcat (s-1) Zn/Zn  Kcat (s-1) Zn/Mn  Kcat (s-1) 
D-Asp-Leu ND ND 
Weak activity 
detected 
β-Asp-Leu ND ND ND 
β-D-Asp-Leu ND ND ND 
Glu-Leu ND ND ND 
Glt-Leu ND ND ND 
 
Table 4, kcat values of different metallo isoforms of DapE  for promiscuous substrate analogues. ND is 
not detectable. NT is not tested. 
 
DapE in presence of manganese is still able to hydrolyse D-Asp-Leu, even though extremely 
slowly, indicating the importance of keeping the right chirality. The structural isomers (14) 
and (15) and longer-chain derivatives (16) and (17) were not hydrolyzed, showing that length 
of the substrate side- chain and their regioisomers are important. .  
 
Effects of Changing distance & types of ligands in the postulated inner coordination 
sphere 
 
Zn2+ is considerably softer, therefore more polarizable, than  Mn2+.23 The binding propensities 
of metal ions with respect to the three possible ligand atoms (O, N, S) found naturally in 
proteins varies depending on the nature of metal and it is also function of the inner 
coordination number of the complex. Mn and Zn have a similar tendency to bind sulphur at 
lower coordination numbers. The main difference for coordination numbers 6 or 7 is the 
larger probability of nitrogen to bind Mn2+.23 We therefore synthesized a series of compounds 
with alternative coordinating moieties (Figure 6), not only to test the difference between the 
ligands to identify other possible promiscuous substrates, but also with the aim of finding 
possible inhibitors of the promiscuous activity.  
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Figure 6. Compounds tested for the Inhibition of native and/or promiscuous activities of DapE. 
 
These compounds were tested as substrate for the three metalloisoforms of DapE and 
surprisingly, only (25) and (26) showed to be slowly hydrolyzed in presence manganese. 
Even though the Kcat is very modest, it is the first time that some prolidase activity is observed 
in DapE. To our knowledge, this finding represents the first description of any promiscuous 
prolidase activity in the litarature. 
 
Inhibition of the promiscuous activity of manganese-DapE    
 
The compounds showed in Figure 4, 5 and 6 were tested as inhibitors of the peptidase activity 
on Asp-Leu (Scheme 3), in presence of Mn-DapE metalloisoform, to have some first 
qualitative evidence of which compounds could have the right properties at the first position 
to coordinate on  manganese and fit with a maximum number of interactions in the active site. 
In Table 5 we report the behaviour of the listed compounds in inhibiting the hydrolysis of 
Asp-Leu.  
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Compound 
Promiscuous activity 
Inhibition 
 
Compound 
Promiscuous activity 
Inhibition 
Asp-Asn ND GABA-Leu Yes (weak) 
Asp-ε-Lys ND Asn-Leu Yes (weak) 
Asp-Lys NT Dab-Leu Yes (IC50 ≈ 5 mM) 
Asp-Ser NT Dap-Leu ND 
Asp-Pro ND Ser-Leu ND 
Asp-iPentyl ND Cys-Leu ND 
D-Asp-Leu ND Dab-Lys Yes 
β-Asp-Leu ND L-Captopril ND 
β-D-Asp-Leu ND Dab-Pro ND 
Glu-Leu ND Cys-Pro Yes 
Glt-Leu Yes (IC50 ≈ 5 mM) D-Cys-Pro Yes 
 
Table 5, Inhibiton or IC50 of promiscuous activity of DapEk using different compounds. ND is not 
detectable. NT is not tested. 
 
The preliminary screening for inhibition of Asp-Leu hydrolysis (Table 5) revealed several 
useful insights: i) we confirmed that the carboxylic acid in α of the second amino acid is 
essential to interact with the active site; ii) the putative coordination of the ligand with 
manganese should form a six-member ring to interact effectively (Figure 7), as revealed by i) 
productive binding for aspartic acid (5) at the first position and unproductive binding for 
diamino-butyric acid in Dab-Leu (20) and ii) the failure to bind with the diamino-propionic 
acid in Dap-Leu (21), where a 5-member ring should be formed, or with glutamic acid on 
Glu-Leu where a 7-member ring should be formed. 
 
Figure 7. Promiscuous substrate and its analogues coordinating to the 2nd metal (Mn) of the binuclear 
metal centre of DapE. 
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Our screening suggests that in the position of the second amino acid a Lys (which is similar to 
DAP in the native substrate) was more effective that Leu. We compared the inhibition effect 
on promiscuous activity of mono-amino containing ligands and di-amino containing ligands 
(Figure 8). Dab-Leu (20), potentially forming a six-member ring with two amines, was a 
better inhibitor than Gaba-Leu (18) and Ala-Leu (30), both of which could coordinate with 
only one nitrogen to manganese. We also found a weak inhibition by Gaba-Leu (18), whereas 
we failed to detect inhibition by Ala-Leu (30), suggesting that the coordination to the nitrogen 
in the α amino group is less effective than an amino group at the γ position, which may be due 
to increased flexibility of the Gaba moiety to orient itself for coordination. We then 
speculated that the combination of diaminobutyric acid with diaminopimelic acid (DAP) 
could represent a good base for a potential inhibitor, because the putative chelating effect of 
the di-amino group would be added to the strong interactions of DAP (part of the native 
substrate) (Figure 8). To test this hypothesis, we synthesized and tested the molecules Dab-
DAP (29), Ala-DAP (31) and Asp-DAP (32). 
 
 
Figure 8. Inhibition profiles of compounds 18, 20 & 30 for DapE-mediated Asp-Leu hydrolysis. 
 
The compounds 29 and 31 were not a substrate for any of the three metalloisoforms, whereas 
Asp-DAP (32) was a poor substrate of the Mn form (kcat = 20 s-1). Compounds 29 and 31 
were found to be effective inhibitors of the promiscuous activity, in particular the diamino-
butyric compound, suggesting that this potentially bidentate interaction on Mn could lead to 
non-productive binding, as previously found for Dab-Leu (20). Dab-DAP (29) was a better 
inhibitor than Ala-DAP (31), with an IC50 of approximately 50 µM (Figures 10 and 11), 
which is compatible with the notion of bidentate binding through a 6-membered ring being 
possible on Mn and providing a strong interaction through chelation. Conversely, of these 
three compounds, only Asp-Dap was a substrate and it appears therefore that the carboxylate 
of aspartyl or succinyl is necessary in lieu of an amino group for productive binding. The 
possibility of formation of a 6-membered ring on Mn with Asp-DAP, although compatible 
	
   90	
  
with catalysis, appears to provide too strong interactions for efficient turnover; hence the Asp-
DAP substrate had a poor turnover and was a competitive inhibitor of the Asp-Leu substrate. 
Surprisingly, however, we failed to detect any inhibition of the native activity with any of 
these compounds, even with the Mn isoform of DapE, suggesting that the enzyme is optimally 
evolved for hydrolysis of the native substrate, which outcompete even inhibitor such as Asp-
DAP and Dab-DAP, especially designed to provide a maximum number of interactions with 
the enzyme. To our knowledge, this is the first example of function-selective inhibition of an 
enzyme, i.e. where the promiscuous activity is inhibited strongly but not the native activity. 
We speculate that such function-selective inhibition may be important in vivo, adding a whole 
layer of complexity in metabolic regulation. 
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Figure 9. Inhibition profiles of compounds 29, 31 & 32 for DapE-mediated Asp-Leu hydrolysis. 
 
 
Inhibitor IC50 
Ala-DAP (31) 0.3 mM 
Asp-DAP (32) 2.5 mM, 90% of activity inhibited* 
Dab-DAP (29) 0.05 mM 
 
Table 6. Inhibition of promiscuous activity. *We considered hydrolysis of Asp-Leu alone as 
representing 100% activity. However, both Asp-DAP and Asp-Leu were substrates and our assay 
could not distinguish their hydrolysis. 
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Figure 10. Inhibition of DapE-mediated hydrolysis of Asp-Leu in presence of Dab-DAP (29) or Dab-
Leu (20). The vertical axis represents percent activity. Inhibitory concentrations are IC50 = 50 µM and 
about 5 mM, for Dab-DAP and Dab-Leu, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. DapE-mediated hydrolysis of Asp-Leu in presence of Dab-DAP. The sigmoidal curve in 
absence of inhibitor, indicative of positive cooperativity, becomes more hyperbolic in presence of 
inhibitor closer to the IC50, where approximately half of binding sites are occupied, i.e. tending to follow 
classical Michaelis-Menten behaviour. 
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Discussion 
 
The promiscuous activity could be based on the different coordination shell of the metals 
in the active site 
 
Divalent manganese, zinc and magnesium, have fundamental roles in biological systems, but 
despite their similar chemical properties (ionic radius, electronic stability), they differ mainly 
on the geometry of their coordination spheres. and molecular orbital and density functional 
calculations. A comparative study of the ligand properties of Zn and Mn, based on the 
analyses of data derived from the structural databases (from the Cambridge Structural 
Database and the Protein Databank) and molecular orbital and density functional 
calculations,23 showed the distribution of coordination numbers for the two divalent metal 
cations in presence of different ligands. The preferred coordination number of divalent 
manganese is six (octahedral), while the preferred coordination is less definite for zinc and 
ranges from 4 (tetrahedral or distorted tetrahedral), to 5 and 6, to stabilize transition state or 
intermediates. Manganese generally binds to oxygen ligands although it is more receptive of 
nitrogen ligands, while zinc prefers nitrogen and sulfur, especially if the coordination number 
is low. 
 
This crucial difference with Zn2+ means that Mn2+ may be able to bind the Asp-Leu substrate 
in a bidentate manner and still be able to expand the coordination sphere to 6-coordinate, to 
stabilize the transition state. In contrast, Zn2+ will not easily expand to a coordination number 
of 6, thereby being unable to hydrolyse the dipeptide, either because the bidentate-coordinated 
form does not allow for transition-state stabilization or because the monodentate coordination 
of substrate does not give sufficiently-strong binding (i.e. KM is too high and the amount of 
substrate too low). We postulate that the binding orientation Asp-dipeptides allows 
complexation of the aspartic acid moiety with Mn2+, with the leucine group occupying 
equivalent position of DAP. On the light of these observations, we also support the notion 
that, for the native activity (hydrolysis of SDAP), the Zn2, which is not involved directly in 
the catalytic cycle is more likely bound to the carboxylic acid of the succinyl-moiety of the 
native substrate, rather than the carboxyl at the α position of DAP. We found that the latter 
appears to be essential for productive binding of the substrate, most probably by forming an 
ionic interaction with an Arg residue conserved at the dimerisation domain of M20 
metallohydrolases, which corresponds to  Arg257 of S.enterica DapE (see Chapter 4).  
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Regarding the role of the catalytic Zn1 involved in the hydrolysis of  SDAP for the native 
activity, our results agree with the proposed mechanism of Nocek, where the activated water 
coordinated by Zn1 hydrolyses the peptidic bond (Scheme 4A). In the ground state, Zn1 could 
either be on a tetrahedral or distorted tetrahedral (coordination number 4) or a trigonal 
bipyramidal (coordination number 5), depending on the mono or bi-coordination of Glu162. 
When the substrate SDAP enters the active site, either the carboxylic group of the peptidic 
bond replaces one coordination bond of Glu162, or Zn expands its coordination sphere from 4 
to 5 (Scheme 4B). 
 
In our proposed mechanism the second metal (Zn or Mn) doesn’t bind to the terminal 
carboxylic group of the second amino acid in the case of native activity on DAP, but rather 
one carboxylic group of the succinic moiety of SDAP (Scheme 4C).  
 
The energy required to expand the valence of Zn from 4 or 5 to 6 must be higher than for Mn, 
and a bidentate ligand like Aspartate in Asp-Leu, appears not to be able to coordinate easily to 
Zn with the aid of the sterically hindered amino group. We postulate that manganese, 
however, can easily expand its valence to 6 and bind a bidentate ligand forming an octahedral 
geometry (Scheme 5). Supporting this notion, Broder and Miller reported weak but detectable 
dipeptidase activity of DapE also in presence of Cd and Co,17 both of which have a reported 
preference for octahedral geometry.24 
 
Our mechanistic insight also provides a reasonable explanation to why carnosinase 2 (CN2), 
which is like DapE also a member of the M20 metallohydrolase family, fails to be 
catalytically active with Zn2+ but  requires Mn2+ exclusively for its enzyme reaction, although 
the fine structures of the respective metal-binding sites with a transition-state 
analogue/inhibitor are highly similar:16 although both Zn ions were crystallised in octahedral 
geometry and, consequently this geometry is undoubtedly thermodynamically feasible in the 
active site of the hydrolase, presumably the kinetic barrier of transition to this geometry is too 
high for productive catalysis in solution. Our postulated mechanism for the coordination 
geometry of the metals and the spatial position of the ligands in DapE are not based on direct 
structural observations such as crystallography, which could prove uninformative in this case, 
but are consistent with the available experimental observations of kinetic behaviour. 
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Scheme 4. A) Reaction mechanism for native activity of the Zn1/M2 metalloisoform of DapE. (M = Zn2, 
Mn2, or No Metal). B) Role of the catalytically active Zn1 in its preferred coordination geometries. C) 
Coordination role of the second metal (M2 = Zn2 or Mn2) on the succinic moiety of SDAP. Graphics 
courtesy, Dr. Gaetano Angelici. 
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Conclusions 
 
In summary, we propose a qualitative explanation for the curious promiscuous dipeptidase 
activity of DapE in presence of manganese, based on our postulate of bidentate interaction of 
the substrate with Mn that cannot occur easily with Zn. Thus, subtle differences in 
coordination preferences can lead to very large differences in catalytic outcomes. A deeper 
understanding of the catalytic site of DapE is expected to provide insights for improved 
design of antibiotics that inhibit cell-wall synthesis in bacteria and may also assist in 
minimizing future antibiotic-resistance mediated by potential evolution of DapE. 
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CHAPTER 7 
 
The fragile birth of novel promiscuous function in the bacterial 
metallohydrolase DapE: why robustness favours the native 
substrate 
 
Abstract 
 
An important aim in protein engineering is to achieve a robust design. For example, for the 
creation of enzyme-like artificial catalysts, one should address not only how enzymes achieve 
such remarkable catalytic proficiencies, but also how they achieve such robustness. 
Laboratory selections for increased promiscuous enzyme-activity suggest that native catalytic 
activities are robust to mutagenesis. However, it remains unclear whether native catalytic 
activities are actually any more robust than their promiscuous activities. Moreover, little is 
known of the underlying molecular mechanisms leading to the emergence of functional 
robustness of enzyme activities or how these mechanisms relate to enzyme evolvability. Here 
we explore the robustness of two enzyme activities in an enzyme, native or promiscuous 
activity, and investigate the underlying molecular mechanisms for their robustness. We used 
neutrally evolved libraries of the bacterial metalloenzyme, DapE, N-succinyl-L,L-
diaminopimelate desuccinylase, selected either for its native desuccinylase activity or for its 
promiscuous dipeptidase activity following random mutagenesis and placing the gene under 
expression of two different promoters. A knockout bacterial strain was used for the selection 
of native and promiscuous activities in bacteria. Variants selected for native desuccinylase 
activity, promiscuous dipeptidase activity and for both activities simultaneously were 
explored for their tolerance to varying DapE expression under either strong or weak 
promoters, enzyme mutational burden and also for metal availability in the culture-medium. 
We found that the native activity of DapE is more robust than its promiscuous activity on all 
variables tested. Our results support the notion that robustness is a systemic property, 
dependent on varied factors like metal availability and level of gene expression. Emerging 
promiscuous enzyme functions rely greatly upon their environment for survival when taking 
their first tentative steps in evolution and toward increased robustness. We predict that such 
insights on mechanisms of functional robustness can be exploited for drug design, biocatalyst 
design and synthetic biology. 
	
   100	
  
Introduction 
 
An important aim in engineering is to achieve a robust design. Robustness can be defined as 
the persistence of a system’s characteristic behaviour under perturbations. Biological systems, 
such as enzyme pathways, exhibit remarkable phenotype resilience to genetic and 
environmental changes.1 In genetic engineering, for example for the creation of enzyme-like 
artificial catalysts,2 one should address not only how enzymes achieve such remarkable 
catalytic proficiencies, but also how they achieve such robustness. 
 
Promiscuity is the capability of an enzyme to catalyse reactions and/or use substrates, in 
addition to its physiologically evolved activity. Laboratory selection for increased 
promiscuous enzyme-activity suggest that native catalytic activities are robust to 
mutagenesis.3 However, it remains unclear whether native catalytic activities are actually any 
more robust than their promiscuous activities. Moreover, little is known of the underlying 
molecular mechanisms leading to the emergence of functional robustness of enzyme activities 
or how these mechanisms relate to enzyme evolvability. 4 
 
The underlying molecular mechanisms for functional robustness pose many fundamental 
problems 4. For example, it has been commonly thought that native activities are driven by 
specific interactions, whereas promiscuous activities are entropy-dominated.4,5 It has also 
been suggested that the evolution of drug-resistance can be minimized with strong and 
enthalpically-driven interactions.6 Although in some cases promiscuous binding activities, 
standing alone, may also be highly specific,7 in general, the available evidence suggests that 
enthalphy-driven, specific interactions are a thermodynamic hallmark of binding that is robust 
to mutagenesis. However, this view presents a paradox, because, intuitively, one would 
expect that a highly specific and enthalpically-driven interaction would be more prone to 
random mutagenic disruption than any promiscuous binding to a “sticky hydrophobic patch”. 
Therefore, an important question to understand robustness is: what are the underlying 
molecular signatures of robust enzyme activities? A final important question that can be 
explored by neutral evolution of promiscuous enzyme activities relates to the design of 
functional robustness: how can knowledge of mechanisms of functional robustness be 
exploited for drug design, biocatalyst design and synthetic biology? 
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The promiscuous enzyme encoded by N-Succinyl-L,L-diaminopimelic acid desuccinylase 
(DapE) offers a useful tool to investigate functional robustness. In a promiscuous enzyme, 
more than one function co-exists in the same enzyme scaffold, thereby minimising the 
confounding effect of structural robustness in evolutionary studies. DapE is an essential 
enzyme for the synthesis of a key component (diaminopimelic acid –DAP-) of the 
peptidoglycan cell wall in gram negative bacteria. Deletion of dapE gene is lethal to several 
pathogenic bacteria and is therefore a target or antibiotic discovery.8 Here we investigate two 
curiously independent activities of dapE in vivo: the native desuccinyse activity (DapE 
activity) and a manganese-dependent, promiscuous peptidase activity (Figure 1).9 
 
 
 
Figure 1. Native and promiscuous activities of dapE. The native desuccinylase activity is Zn2+-
dependent, although it is also functional with Mn2+.10,11 The promiscuous activity is strictly Mn2+-
dependent.9 
 
The robustness of promiscuous or native activity can be assessed and quantified by selection 
in a genetically-modified bacterial strain.9 We neutrally evolved the bacterial DapE for either 
its native desuccinylase activity or for its promiscuous dipeptidase activity using laboratory 
evolution to explore its functional robustness. Here we provide what is, to our knowledge, the 
first published direct evidence showing that a native activity is more robust than a 
promiscuous activity and provide insights for such robustness of the native enzyme activity. 
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Materials & Methods 
 
Minimal medium, E-medium,12 supplemented with 0.4% glucose and a 0.4 mM concentration 
of the appropriate amino acids and/or dipeptides (Bachem) was used as a minimal medium 
and LB-medium was used as a rich medium. As a supplement, 1 mM meso-diaminopimelate 
(mDAP) and IPTG were added (Bachem). Sodium ampicillin, Kanamycin, tetracycline and 
chloramphenicol were used at final concentrations of 30, 100, 5 and 34 µg/ml, respectively, 
when added to either liquid or solid medium. Electro competent cells of S.enterica and 
chemical competent cells of E.coli were prepared by standard protocols. Agar (used at 1.5 %) 
and agarose (used at 1 %) were purchased from Invitrogen. T4-DNA ligase, XhoI HindIII and 
other restriction enzymes are from New England Biolabs, unless specified. All other 
chemicals were purchased from Applichem, unless otherwise specified. Primers were 
synthesized from Microsynth, Switzerland and the gene sequencing was from Starseq, 
Germany. 
 
Construction of Random mutagenesis libraries 
 
In the first round of evolution the mutant library was constructed starting from a wild type 
S.enterica dapE gene, ~1.2Kb, was PCR amplified by GeneMorph® II Random mutagenesis 
kit, Stratagene, from the plasmid pCM655-dapE containing kanamycin resistance gene, 
primers (F & R-SEQ-pCM655). In second round two variants of the first round were used as 
templates and in the third round four variants of the second round were used as templates in a 
single-pot random PCR (Figure 2). The rate of mutagenesis at each round was controlled by 
using 0.5µg target DNA as a PCR template and by limiting the number of PCR cycles to 25, 
to obtain low to medium mutational frequency (0 to 4.5 mutations per kb).  
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Figure 2. Overview of laboratory evolution by random mutagenesis, recloning and selection. 
 
Cloning of random mutagenesis libraries 
 
In the original plasmid, pCM655,9 S.enterica dapE gene has a HindIII restriction site on either 
side of the dapE gene, which has a Ribosomal Binding Site (RBS) close to the start codon and 
the cloning strategy was designed in such a way that the gene is always cloned along with this 
RBS (Figure 3). Random mutagenesis with Genemorph II / normal PCR product with pfu 
Turbo polymerase was subjected to DpnI digestion to minimize the background of wild type 
gene and PCR template plasmid and then digested with HindIII, purified by PCR clean-up kit, 
(Machery-Nagel) and ligated (T4 DNA ligase, 2 hours at room temperature) with HindIII 
digested pCM699 vector containing Ampicilline resistance marker gene to avoid the 
background of the undigested and supercoiled plasmid template of the PCR random 
mutagenesis which contains kanamycin resistant marker gene, (Figure 2). The plasmid 
pCM699 was derived from pCM655, in which the dapE gene was deleted by HindIII 
restriction digestion and the empty plasmid vector was religated forming a single HindIII 
cloning site. The pCM699 has two promoters, a strong and IPTG inducible lac promoter and 
another weak and un-inducible phoB promoter, as assessed by BPROM (Softberry, Inc.), 
upstream and downstream of the single HindIII cloning site, respectively. Consequently, the 
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PCR amplified dapE gene / dapE mutant library digested with HindIII on either sides can be 
cloned into the HindIII digested plasmid vector, pCM699, in one of the two possible 
orientations. If the dapE gene is cloned in the forward orientation relative to the lac promoter 
it will be under the strong promoter (for wild type dapE gene pCM655) and if the gene is 
cloned in the reverse orientation it will be under the weak promoter (for wild type dapE gene 
pCM656) (Figure 3). 
 
 
 
 
Figure 3. dapE gene under two different promoters in the plasmid. The two plasmids, pCM655 (gene 
under strong promoter) and pCM656 (gene under weak promoter).  
 
Transformation 
 
Transformation into S.enterica strain (TN5911),9 which has all 7 genes of aspartyl 
dipeptidases and dapE gene knocked-out and it is also an auxotroph for leucine and proline; 
therefore, mDAP has to be supplemented in enriched media. In minimal medium, in addition 
to mDAP, supplementation of  leucine and proline is also required. The strain TN5911 was 
used for the construction of various strains (Table 1) by transforming different plasmids 
(Table 1) through electroporation.  
 
Electroporation 
 
Electroporation of 100µl electro competent cells and 5 to 10µl ligation product or plasmid 
DNA in 0.1cm cuvettes (Axon labs) at 1.8Kv for ~5msec and the cells were recovered with 
0.1 to 0,2ml of SOC medium and incubated for 1 hour at 370C in a shaking incubator of 
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200rpm. The recovered transformation mixture was briefly centrifuged for 1minute at 
4000rpm to collect the cells or dilute to 100 to 1000 times in order to get rid of the rich 
medium as the further enzyme activity selections on minimal medium. The resuspended or 
diluted cells in sterile M.Q.H2O were plated for single colonies under different selection 
conditions (selection for native activity, promiscuous activity and for both activities at the 
same time) and also with a plasmid marker, ampicillin, to check the transformation efficiency.  
 
Selection for different enzyme activities in bacteria 
 
The native activity selection of DapE were carried out without supplementation with mDAP, 
either in rich medium (LB-medium) or on minimal medium (VB-medium). Promiscuous 
activity was selected in minimal medium by supplementing Asp-Leu dipeptide as a source of 
leucine and mDAP for compensating the native activity. For selecting both native and 
promiscuous activities at the same time only Asp-Leu dipeptide was provided a leucine 
source but not mDAP source in the medium. If the selection was under minimal medium, it 
was also possible to check if the DapE enzyme was active / efficient enough to produce 
sufficient DAP for cell-wall synthesis as well as for the precursor of the lysine synthesis, 
when selected for native activity and for both activities at the same time by supplementing 
with or without lysine. 
 
Effect of selection conditions for pCM655 and pCM656 on bacterial growth 
 
Selection for native activity in rich medium (LB-medium) under the strong or weak promoter 
did not influence the growth when induced with or without IPTG, but the growth was 
consistently slower under the weak promoter compared to the strong promoter, irrespective of 
IPTG supplementation (Figure 4A). Bacteria selected for native activity in minimal medium 
(VB-medium) under the strong promoter without IPTG grew much better than with IPTG, 
which we interpret as arising from possible toxicity of over-expression of DapE. In minimal 
medium, selection for native activity under the weak promoter is largely unaffected by IPTG. 
 
	
   106	
  
 
 
Figure 4. (A) Growth of the dapE knock-out of S.enterica containing plasmid-encoded DapE in 
regulated by strong or weak promoters, cultured under selection for native activity (in LB & VB-
medium) and promiscuous activity (in VB-medium). Culture growth was monitored by measuring the 
OD600nm after 10 hours in LB-medium and 24 hours in VB-medium. (B) Schematic drawing of different 
levels induction of both sense and antisense RNA. 
 
Growth for promiscuous activity selection is very slow under the strong promoter with IPTG 
compared to without IPTG suggesting that the over-expression of DapE is toxic to the 
bacteria, as noticed also under the native selection in minimal medium. Growth under weak 
promoter with IPTG is ten times slower compared to without IPTG. We interpret this finding 
as IPTG inducing the transcription of anti-sense RNA from the strong promoter and this RNA 
can interfere with the RNA of the sense strand, thereby blocking the expression of DapE 
(Figure 4B). In contrast, in absence of IPTG, the amount of transcription of anti-sense RNA is 
likely lower than the transcription of sense mRNA, thereby allowing sufficient DapE 
expression for the growth of the bacteria (Figure 4). 
 
Phenotypic validation of the selected variants 
 
All selected plasmids were isolated and retransformed into TN5911 for phenotypic validation 
in selection media. This precaution was intended to ensure that the DapE-mediated phenotype 
was plasmid-encoded and not an artefact of any genomic mutations.  
 
 
 
 
 
A B 
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Cloning of dapE in pET28b for constructing C-terminus 6His-DapE 
See Chapter 3 and Figure 5. 
 
Primers Sequence (5‘ to 3‘) 
F-SEQpCM655 GCGTACGTCGCGACCGCGGACATGT 
R-SEQpCM655 GCGTACGTCGCGACCGCGGACATGT 
R-pCM655XhoI AGCCAAGCCTCGAGGGCGACGAGCTGTTCC 
F-pET28HindIII  CCCTCTAAAGCTTAAGGAGATATACC 
R-pET28HindIII GTTAGAAGCTTGATCTCAGTGGTGGTGGTG 
F-DapE AATTTTTGGGCATGGCGTGGGC 
R-DapE TCA GGC GAC GAG CTG TTC CAT 
Plasmids Genotype 
pCM6559 Plasmid with Wt dapE gene under strong promoter, Ampicillin 
pCM656 this work pCM655 with Wt dapE gene under weak promoter, Ampicillin 
pCM657 this work pCM655 with Wt dapE-C6His under strong promoter, Ampicillin 
pCM658 this work pCM655 with Wt dapE-C6His under weak promoter, Ampicillin 
pCM699 13 pCM655-Empty plasmid (without dapE gene), Ampicillin 
pET28b Kanamycin 
pET28b-dapE-HindIII  
this work 
pET28b with dapE between HindIII and XhoI. Kanamycin 
Table 1. Summary of primers and plasmids used in this study. 
 
S.enterica strains Genotype 
TN59119 Knockout strain for dapE, 7 aspartyl dipeptidases & leucine auxotroph 
TN59359 TN5911 + pCM655 
TN5936 this work TN5911 + pCM656 
TN5937 this work TN5911 + pCM657 
TN5938 this work TN5911 + pCM658 
TN595913 TN5911 + pCM699 
 
E.coli strains Genotype 
BL21DE3 BL21 (DE3) 
BL2125 this work BL 21 (DE3) + pCM655 
BL2126 this work BL 21 (DE3) + pCM656 
BL2127 this work BL 21 (DE3) + pCM657 
BL2128 this work BL 21 (DE3) + pCM658 
BL2129 this work BL 21 (DE3) + pCM699 
BL2130 this work BL 21 (DE3) + pET28b 
BL2131 this work BL 21 (DE3) + pET28b-dapE-HindIII 
Table 2. Summary of bacterial strains used in this study. 
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PCR 
 
Single colonies were re-suspended in 50µl of sterile M.Q.H2O and 5µl of this cell suspension 
was used as a template for each colony PCR. For most of the PCR the following conditions 
were used, hot start PCR, with initial 95°C for 3 minutes, then 25 cycles of 95°C/ 1 minute, 
60°C/ 1 minute and 72°C/ 2 minutes, with a final extension of 10 minutes at 72°C. Since the 
colony PCR was only for analytical purpose Taq DNA polymerase (Telongation 72°C) was used. 
However, whenever the PCR amplified product needed to be used for further cloning or sub-
cloning Pfu Turbo DNA polymerase (Telongation 68°C) was used in order to avoid the errors of 
the Taq DNA polymerase. The genemorph II mutagenesis kit (Telongation 72°C) was used for 
random mutagenesis. 
 
 F-primer R-primer PCR amplicon Gene orientation Promoter type 
1 F-DapE R-SEQpCM655 Yes Forward Strong 
2 F-SEQpCM655 R-DapE Yes Forward Strong 
3 F-SEQpCM655 R-SEQpCM655 Yes Cannot distinguish  
4 F-DapE F-SEQpCM655 Yes Reverse Weak 
5 F-SEQpCM655 R-DapE Yes  Reverse Weak 
 
Table 3: primers for the identification of the orientation of the gene in pCM plasmid constructs. 
 
 Component Quantity Concentration Note 
1 DNA / cells 0.01µg to 0.5µg  5µl of cells for colony PCR 
2 Buffer 5µl 1X As per the DNA polymerase 
3 DMSO 2µl 4%  
4 dNTP’s 2µl 0.mM each 1.6mM dNTP’s mix 
5 F-primer 1.5µl 0.3µM  
6 R-primer 1.5µl 0.3µM  
7 DNA Polymerase 0.5µl to 1µl  Taq DNA polymerase 
Pfu Turbo DNA polymerase 
Genemorph II Mutagenesis kit 
8 DNase free water To 50µl   
 
Table 4: Components and concentrations of the PCR reactions. 
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Cloning of C6His-dapE from pET28b to pCM699 
 
The C6His-tag DapE was cloned into the pCM699 vector backbone in order to validate the 
enzyme activity of the C-terminus 6xHistidine-tagged DapE in bacteria by phenotypic 
validation. The primers used for this cloning were, F-pET28HindIII and R-pET28HindIII 
with pfu Turbo polymerase and then the PCR amplified C6His-tag DapE and pCM699 vector 
were digested with HindIII restriction site. Since the gene could be cloned in two possible 
orientations in pCM699, the wild type C6His-tag DapE in forward orientation was placed 
under strong promoter (pCM657) and the gene in reverse orientation was placed under the 
weak promoter (pCM658). The 6xHistidine-tagged DapE complemented native and 
promiscuous activities under both the promoters comparable to non his-tagged DapE. 
 
Figure 5. SDS-PAGE showing the purified C6His-tagged DapE of ~42.5KDa. 
 
DapE kinetic assays. 
See Chapter 3. 
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Results 
 
Random mutagenesis leads to more survivors for native than for promiscuous activity  
 
Genetic robustness of DapE enzyme function was assessed by random mutagenesis and by 
placing the gene under expression of two different promoters for selection (Figure 3). 
 
When the dapE gene randomised library was selected for native activity there were 
consistently more colony-forming units (cfu) than when selected for promiscuous activity or 
for both activities at the same time (Figure 6). The number of colonies when selecting for 
promiscuous activity or for both activities selection was similar, but always less than under 
selection for native activity. This observation was independent for the type of PCR template 
used for randomisation, i.e. a single wild type dapE gene or one or more dapE variants, 
previously pre-selected for one or the other or both activities at the same time, amplified in 
one-pot PCR randomisation. 
 
Figure 6. Percentage of survivors form a randomised library of DapE, selected for native activity, 
promiscuous activity and for both activities at the same time, compared to survivors in absence of any 
selection for DapE (only selected for plasmid transformation through ampicillin resistance). This 
experiment carried out in triplicates under identical conditions is representative of 4 different 
experiments carried out with different mutational rates leading to similar conclusions. 
 
The finding that selection for both activities at the same time leads to similar survival rate as 
for promiscuous activity suggests that the native activity imposes little additional selection 
pressure to the promiscuous activity. Taken together the promiscuous activity is very sensitive 
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to mutational burden compared to the native activity; since selection for the native activity 
leads to more survivors than promiscuous activity, the native activity of DapE in vivo is more 
robust to mutagenesis than its promiscuous activity. 
 
Selection pressure for DapE function biases the promoter preference 
 
The cloning strategy that we used for the construction of the random gene libraries (Figures 2 
& 3) is a novel selection method for screening the randomised libraries at a range of selection 
pressures controlled by protein-dosage (Figure 4) within a single experiment. The cloning 
strategy was designed in such a way that the dapE gene can be cloned either under the strong 
and inducible lac promoter or under the weak and un-inducible phoB bacterial promoter, 
which provides 50% chances for dapE wild type or variant gene to be cloned under any one 
of the two promoters. In order to prove that this concept is experimentally true, we selected 
the randomised library only for the plasmid marker gene (Ampicillin) and with no selection 
pressure for any of the enzyme activities. As expected, the gene insert was found in either 
orientation, with about 50% occurrence for each of the two possibilities (Figure 7).  
 
 
Figure 7. Percentage of survivors under strong and weak promoters when selected for plasmid marker 
gene, Ampicillin, resistance with no selection pressure for any of the enzyme activities. 
 
When the randomised library was selected for native activity, almost 50% variants survived 
under each of the two promoters (Figure 8) in a similar manner to the percentage of survivors 
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under no selection pressure (Figure 7), suggesting that the native activity is on average 
insensitive to low expression level even under the mutational burden imposed in the 
experiments. Knowing that the wild type has native activity under the weak promoter, it is 
reasonable to assume that some variants may show a bias towards the strong promoter for 
compensating the mutational burden; however, our results showed that the percentage of 
survivors for native activity at each promoter are almost equivalent. It is noteworthy that in 
neutral evolution it is also possible to have (rare) variants with improved native activity under 
either promoter. However, we did not proceed to expressing and characterising the variants 
kinetically any further. 
 
 
Figure 8. Promoter preference under selection pressure for native activity, promiscuous activity and for 
both activities at the same time. 
 
When selected for promiscuous activity and also for the both activities at the same time, there 
are no survivors under the weak promoter. Our control experiments showed that wild type 
DapE had no promiscuous activity under the weak promoter at the very stringent selection 
condition (Figure 4). During selection of random libraries, we did not find any variant under 
the weak promoter with promiscuous activity (0/57 selected for promiscuous alone or 0/85 
selected for both activities). However, we identified 1 variant, M4B3, out of 87 variants 
cloned in reverse and phenotypically cross-validated, that maintain promiscuous activity 
under the weak promoter even with stringent IPTG selection. We hypothesise that variant 
M4B3 may have improved promiscuous activity compared to the wild type, as it has been 
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selected under the very stringent selection conditions, i.e. under weak promoter with IPTG; 
however, we did not explore this variant any further, neither kinetically nor for robustness. 
 
Selection for native activity led to a similar number of survivors cloned under the strong 
promoter and weak promoter. In contrast, the absence any survivors when originally selecting 
for promiscuous activity and found to be cloned under expression of the weak promoter 
strongly suggests that the native activity tolerates lower levels of expression than the 
promiscuous activity. Similar conclusions are suggested already from growth profiles under 
different selections (Figure 4) as well as the fact that IPTG induction under the weak 
promoter is incompatible with DapE wildtype selection of promiscuous activity, whereas 
these conditions do not hinder survival of DapE wildtype under native selection. In summary, 
bacteria need more DapE to survive when the dipeptidase activity is required than when DAP 
availability is required; since most mutations are deleterious, most DapE variants cannot 
survive at all under the weak promoter for promiscuous activity, in contrast to native activity. 
 
Effect of lysine supplementation on the promoter preference 
 
DapE is a metallo-hydrolase present in the lysine biosynthetic pathway producing mDAP, 
which is one of the essential components of the bacterial cell wall and also precursor for the 
lysine synthesis. The promiscuous activity in bacteria, throughout this chapter, is always 
referring to the hydrolysis of a dipeptide, Asp-Leu, producing the free amino acids, aspartic 
acid and leucine. The dapE knock-out bacterial strain used for the screening of the random 
libraries is also leucine auxotroph. Leucine has a huge requirement for the cellular 
metabolism compared to the amount of mDAP required for the cell wall synthesis and hence 
we wanted to know if the DapE native activity is rate limiting for lysine synthesis, which in 
turn may affect the difference in the percentage of survivors and also the promoter preference 
between native and promiscuous activities.  
 
Although we found that, on average, genes selected for the native activity could be found 
either under expression of the strong or weak promoter with little preference (Figure 9), closer 
analysis revealed a bias for the weak promoter of variants selected in presence of lysine (44 % 
forward, n = 39) and a stronger bias for the strong promoter when variants were selected in 
absence of lysine (66% forward, n = 38). This bias suggests that the selection pressure for the 
native activity was different in both selection conditions (Figure 10). Similar trends were seen 
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cumulatively, even when considering very different mutational rates from a variety of 
different DapE libraries preselected for various conditions (Figure 11). We interpret the bias 
against a strong promoter in the presence of lysine to toxic effects of DapE overexpression, as 
suggested also in growth curves of wildtype DapE in minimal medium (Figure 4A). In 
contrast, it appeared advantageous to express DapE under the strong promoter for most 
variants when selecting stringently for native activity, i.e. in absence of lysine, possibly 
because most variants required high enzyme expression to cope with the requirement for 
sufficient DAP product, both for cross-linking the peptidoglycan cell wall as well as lysine-
biosynthesis. It is noteworthy, when comparing stringent selection for native activity and for 
promiscuous activity, i.e. both in minimal medium and supplementing either with leucine or 
mDAP, respectively, that the native activity still appears more robust to mutagenesis. This is 
surprising, considering that in both of these conditions, DapE is selected to genetically 
complement the requirement for an essential amino acid (lysine or leucine). 
 
 
 
Figure 9. Survivors for native, promiscuous and both activities at the same time with and without 
lysine. 
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Figure 10. Promoter preference under selection for native activity either in presence or absence of 
lysine supplementation; for promiscuous activity and for both activities at the same time. Selection was 
carried out in presence of 1 mM IPTG in VB-minimal medium. 
 
 
 
 
 
Figure 11. Percentage of survivors with and without Lysine supplementation for native activity and also 
for the promiscuous activity, based on 9 different randomised libraries arising from different templates 
(hence large error bars). 
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Overall, ratio of survivors for native activity over survivors of promiscuous activity is 3.5 
times and 3.2 times with and without lysine in native selection, respectively (Figure 12). We 
conclude from these ratios: i) that survival under native activity compared to promiscuous 
activity (Figures 6 & 9) is not due exclusively to lysine supplementation and ii) nor to the 
possibility that the native activity can be under both the promoters but not the promiscuous 
activity, in which case one would predict a ratio of two if both were equally robust. Taken 
together, we conclude that the larger number of survivors for the native activity are due to the 
functional robustness of the native activity over the promiscuous activity, independent of 
lysine supplementation and promoter strength, although both these factors obviously 
contribute to survival upon selection for native activity. 
 
 
Figure 12. Ratios of percentage of survivors of native activity with and without lysine over the 
percentage of survivors of promiscuous activity. 
 
Robustness of native activity over the promiscuous activity is maintained in directed 
evolution by sequential randomisations. 
 
In the first two rounds, the percentage of survivors for native activity was more than three 
times more than for either promiscuous activity or both activities (Figure 13). The percentage 
of survivors for both activities was slightly lower than the survivors of promiscuous activities, 
which may be due to high selection pressure, as the enzyme has to perform both the activities 
at the same time and to mutagenic conditions of this experiment. The results of 1st round were 
reproduced in four independent experiments and the results of the 2nd and 3rd rounds of 
randomisations were reproduced each round in two independent experiments, with similar 
results. 
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Figure 13. Survivors for the three rounds of randomisations, process of sequential evolution of DapE. 
 
In the third round the percentage of survivors for native activity was 110 times more than the 
promiscuous activity and the percentage of both activities was 30 times more than the 
survivors of both activities; however, such extreme differences in survival rate in this 
particular experiment were due to the survival of only one variant for promiscuous activity in 
two replicate experiments; this one surviving variant at the 4th generation was identical to one 
of the four templates used for the one-pot PCR randomisation of the 3rd generation, 
suggesting the template variants have already reached the maximum mutational tolerance for 
the promiscuous activity and that further active mutants are not easily accessible. We 
confirmed that the loss of promiscuous activity in the 3rd round of randomisation was not a 
rare “founder effect”: the initial founders (templates of the 2nd round) used for the 
randomisation reproducibly gave survivors for promiscuous activity at similar frequencies to 
controls from the 1st round of randomisation. These control experiments suggested that the 
template variants did not have drastic mutations. However, using the templates of the 3rd 
round in two independent experiments led to lineage extinction (or near-extinction). This 
conclusion in our evolutionary experiments supports the notion that the promiscuous activity 
is more sensitive, as it approaches the apparent maximum limit of mutational burden more 
easily than the native activity.  
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Promiscuous activity is more easily lost than native activity. 
 
In order to check the robustness of the native activity over promiscuous activity, we cross-
validated the survivors selected for one enzyme activity for the other enzyme activity and 
found that native activity was always maintained for the variants selected for promiscuous 
activity, i.e. 100% survivors of promiscuous activity maintain the native activity, whereas for 
native activity about 17% of the survivors under the strong promoter lost promiscuous activity 
(Figure 14); maintenance of the promiscuous activity under the weak promoter was extremely 
rare (only one variant, M4B3, as discussed above).  
 
 
 
Figure 14. Cross validation of survivors of native activity for promiscuous activity and vice versa.  
 
Promiscuous activity survivors always maintaining the native activity and native activity 
survivors often losing the promiscuous activity, supports the notion that the native activity is 
more robust to random mutagenesis than the promiscuous activity (Table 4). 
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 Variant Genotype 
1 10.A2 F114S , A208T & R297H 
2 8+10.A9 W219R  & A228V  
3 3A5.A3 D44Y, G46V, F51L, A98V, T166S, L199P, E313D & A375V 
4 3A5.A4 D44Y, G46V, F51L, A98V, T166S, L199P, S242T & E313D 
5 3A8.A3 A98V, V142I, T166S, A228V, T320M & N344Y 
6 3A8.A7 P71L, A98V, T166S & A228V 
7 3A5+3A8.A9 A98V, T166S, A228V & R364H 
9 M3B4 D171N 
10 M4A2 T320K 
11 M5A4 P16T, G46S, R57H, A105T & V252M 
12 M6A1 H198D & V204A 
 
Table 4. Variants that lose promiscuous activity under strong promoter and maintain the native activity. 
 
Native activity is more robust to the mutational burden 
  
The mutational burden (total mutations or non-silent mutations or drastic mutations per gene) 
for ampicillin selection is similar under both strong and weak promoters, which is expected as 
there is no selection pressure for the enzyme activity (Figures 14 and 15). When selected for 
native activity the mutational burden appears to be lower compared to no selection pressure. 
Moreover, within variants selection for native activity, those expressed under the strong 
promoter appear to tolerate more drastic mutations than the variants under the weak promoter 
(Figure 15). These trends suggest that the over-expression of protein can compensate for the 
mutational burden to some extent and, conversely, that lower expression lowers the tolerance 
to mutational burden. 
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Figure 15. Mutational burden (number of mutations/gene) when selected for ampicillin (no selection 
pressure for the enzyme activity), native activity, promiscuous activity and for the both activities at the 
same time. 
 
Native activity appears to tolerate more mutations than the promiscuous activity, especially 
drastic mutations. Further, the native activity under the weak promoter appears to tolerate 
more drastic mutations than the promiscuous activity (Figure 16) supporting the notion that 
the native activity is more robust to mutational burden compared either to promiscuous 
activity or to selection for both activities at the same time. Overall, the tolerance to mutational 
burden, particularly the drastic mutations, appears higher for native activity under strong 
promoter than weak promoter. The native activity under weak promoter has more tolerance to 
drastic mutations than promiscuous and than both activities at the same time, even though 
these were always found under strong promoter. 
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Figure 16. Tolerance to drastic mutations per gene when selected for ampicillin (no selection pressure 
for the enzyme activity), native activity, promiscuous activity and for the both activities at the same 
time. Drastic mutations were identified according to ClustalW. 
 
Effect of lysine supplementation on mutational burden 
 
Since we already found that the lysine supplementation allows the survival of more variants 
for native activity under the weak promoter compared to no lysine supplementation, we were 
curious to know if the lysine supplementation can also have an effect on the tolerance to 
mutational burden. Native activity under weak promoter without lysine supplementation 
appeared to tolerate both fewer non-silent and fewer drastic mutations compared to selectants 
with lysine (Figures 17 and 18). These data confirmed that lysine greatly influenced selection 
pressure, as determined by tolerance to mutational burden, which is consistent with our 
finding in having more survivors under weak promoter when supplemented with lysine. 
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Figure 17. Mutational burden (number of mutations/gene) when selected for native activity with the 
effect of lysine supplementation on tolerance to mutational burden under the strong and weak 
promoters compared to the mutational burden of the promiscuous activity. 
 
 
Figure 18. Tolerance to drastic mutations per gene when selected for native activity and the effect of 
lysine supplementation on mutational burden under the strong and weak promoters, compared to the 
mutational burden of the promiscuous activity. Drastic mutations were identified according to the 
ClustalW. 
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Role of metal availability on the native or promiscuous activities 
 
Initially, the effect of metal supplementation was tested on the wild type DapE and found that 
Mn supplementation helps the growth under promiscuous activity selection as well as native 
activity selection compared to no metal supplementation, whereas the Zn supplementation 
does not affect the growth under native activity but certainly inhibits the growth under 
promiscuous activity selection (Figure 19). These data suggest that the native activity is 
robust to changes in metal availability and the promiscuous activity is sensitive, especially to 
Zn supplementation. 
 
 
Figure 19. Growth curves of bacterial cultures selected for native desuccinylase activity (A) or 
promiscuous dipeptidase activity (B) with and without metal supplementation in minimal medium. Note 
that Mn2+ accelerates growth of the culture appreciably when selecting both for native and 
promiscuous activity. Plotted are representative curves from two independent experiments. 
 
We also explored if metal supplementation had any effect on DapE variants under selection, 
by semi-quantitatively determining the size of the colonies in a blind-assessment. 
We found that Mn supplementation allowed better growth of variants, compared to Zn or no 
metal supplementation, only when selecting for promiscuous activity, whereas the metal 
supplementation (Zn or Mn) did not provide any advantage for the growth under native 
activity selection (Figure 20).  
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Figure 20. Growth of the DapE variants when selected for native and promiscuous activity with Zn and 
Mn supplementation. Number of variants observed in total: 134. 
 
Role of metal availability at various DapE expression levels 
 
For the wild type DapE and the other variants tested (Table 5) when selected for promiscuous 
activity, Mn supplementation helped the growth and Zn supplementation inhibited the growth 
under both promoters, particularly seen under the weak promoter (Figure 21B, colonies 2, 3, 
5, & 8) compared to strong promoter (Figure 21B, colonies 1, 4, 6 & 7). In Figure 21B 
Colonies 9 and 11 were under strong promoter and did not show promiscuous activity even 
with metal supplementation (Zn or Mn) as these variants have already lost promiscuous 
activity during the three rounds evolution for native activity, as described above; it is obvious 
that their counterparts under the weak promoter (Figure 21B, colony 10 & 12) do not survive 
for promiscuous activity. Note that, in this experiment there is no IPTG supplementation and 
hence the wild type and the other variants can survive under the weak promoter, especially 
with Mn supplementation. In this experiment, we observed little difference in growth for the 
variant M4B3 (Figure 21B, colonies 3, 5 & 8) selected for promiscuous selection under weak 
promoter, compared to the wild type (Figure 21B, colony 2). However, this variant may have 
kinetically improved promiscuous activity compared to wild type, as M4B3 was originally 
selected under weak promoter with IPTG, which is the most stringent selection for 
promiscuous activity at which wild type cannot survive. For native activity, metal 
supplementation does not make any difference in the growth compared to no metal 
supplementation (Figure 21A), suggesting that the native activity is very robust to changes in 
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metal availability. Conversely, it appears than Mn bioavailability is limiting for survival of 
many variants only under promiscuous selection.  
 
 
Figure 21. Growth of the wild type and variants of DapE selected for native activity (A) and selected for 
promiscuous activity (B) on minimal medium without IPTG. For each enzyme activity selection, the top 
plate is without any metal supplementation, left plate with 1mM Mn and right plate with 1mM Zn 
supplementation. Each plate has 12 variants, numbered 1 to 12, including the wild type, and each 
variant is at three dilution factors (DF), 4X, 100X and 1000X. Images were taken after 65 hours at 
37°C. See Table 5 for a description of variants used here. 
 
 
Figure 22. Effect of IPTG on the weak promoter. Growth of the wild type and variants of DapE in 
presence of Mn, selected for native activity (left) and selected for promiscuous activity (right) on 
minimal medium. Each plate has 12 variants, numbered 1 to 12, including the wild type and each 
variant is at three dilution factors (DF), 4X, 100X and 1000X. Images were taken after 65 hours at 
37°C. See the table 4, for the labelling of the colonies.   
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Using on phenotypic validation of variants on solid media, we confirmed that IPTG induction 
under strong promoter (both for native and promiscuous activities) appears to have some 
inhibition on the growth, suggesting that the over expression of the DapE protein is may have 
high metabolic burden / toxic effect on the bacteria. Secondly, it is very evident that the IPTG 
induction under weak promoter always (including wild type) inhibits promiscuous activity 
(Figure 22, colonies 2, 3, 5, 8 & 10) and also the native activity of few variants, (Figure 22, 
colony 10), but never wild type.  
 
Finally, we identified a few variants that lost native activity under the weak promoter, whilst 
maintaining activity in the forward, such as 3A1 (Figure 21A, colony 10). Loss of native 
activity under the weak promoter more pronounced with IPTG stringent selection condition 
(Figure 22, native activity with IPTG, colony 10), although it maintains native activity under 
the strong promoter (Figure 21A, colony 9). Besides losing native activity under weak 
promoter, 3A1 also loses promiscuous activity under the strong promoter (Figure 21B, colony 
9), suggesting that the mutations of this variant are decreasing overall enzyme activity, 
perhaps due to instability.  
 
Colony No. Variant name Clone number Promoter 
1 Wild type 
DapE 
1 Strong 
2 10.4 Weak 
3 M4B3 M4B3 Weak 
4 2.3 Strong 
5 2.9 Weak 
6 2.12 Strong 
7 2.13 Strong 
8 2.16 Weak 
9 3A1 3A1 Strong 
10 3.15 Weak 
11 3A5 3A5 Strong 
12 4.7 Weak 
 
Table 5. List of the DapE wild type and variants selected for native and promiscuous activities with and 
without metal supplementation. 
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From figure 13, there were 17% of native activity variants that lost promiscuous activity even 
under the strong promoter, such as 3A5 (Figure 21B, colony 11) whilst maintaining native 
activity both under strong and weak promoters (Figure 21A, colony 11 & 12 respectively). 
Since 3A5 lost only promiscuous activity under strong promoter but maintained native 
activity under both promoters, it is most likely that the mutations of this variant are 
preferentially losing the promiscuous over native activity due to intrinsic mutational effects 
on DapE affecting catalysis. 
 
2nd metal, Mn, is crucial for the promiscuous activity. 
 
We found that mono-Zn form (Zn1/--) and di-Zn form (Zn1/Zn2) of DapE can have only native 
activity and cannot perform promiscuous activity in vitro. Promiscuous activity can only 
occur in a mixed metal form (Zn1/Mn2) of the enzyme (Table 6), as previously reported.9 
 
DapE metalloisoform Native activity Promiscuous activity 
 kcat (s-1) kcat (s-1) 
Zn1/-- 300 0 
Zn1/Zn2 700 0 
Zn1/Mn2 1100 500 
 
Table 6. kcat values of native desuccinylase and promiscuous dipeptidase activity of different 
metalloforms of DapE. 
 
Randomisation by site-directed mutagenesis around 2nd metal suggests promiscuous 
activity is especially sensitive to mutagenesis. 
 
A library generated by the site specific random mutagenesis at the 2nd metal coordination 
residue H348 and two other residues in the close proximity of 2nd metal, that can potentially 
influence the metal coordination are N344 and I347, was screened for the native and 
promiscuous activity with the metal supplementation, either Zn or Mn. To simplify analysis, 
this site specific mutagenesis library was generated to have the DapE only under the strong 
promoter and therefore no effect of weak promoter. When selected for native activity the 
number of survivors was in the same order of magnitude for Zn and Mn supplementation, 360 
& 430 respectively (Figure 23). These results are consistent with the notion that the 2nd metal 
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can either be Zn or Mn for native activity also in vivo and that native activity is robust for 
such changes in the metal. Congruently, in vitro (Table 5) the 2nd metal was not crucial for the 
native activity as the native activity can also occur with mono-Zn form of the enzyme, albeit 
less efficiently than the di-Zn form form of the enzyme. In marked contrast, when selected for 
promiscuous activity, Zn supplementation totally hindered survival of any mutants in the 
library in this experiment. 
 
 
Figure 23. Number of survivors from the site specific randomisation of 2nd metal coordinating residue 
H348 and other nearby residues, N344 & I347, selected for native activity and promiscuous activity 
either with Zn or Mn supplementation in the minimal medium.  
 
The library under selection for promiscuous activity had much fewer survivors even with Mn 
supplementation compared to native activity with Mn supplementation (67 vs 430). i.e. even 
with Mn supplementation, native activity is more robust to mutations than promiscuous 
activity, in this case by more than 6-fold. Native activity was largely unaffected by presence 
of Zn or Mn, determined by the similar number of selectants with either metal in this focused 
library, as found also for random mutant libraries. We conclude that the promiscuous activity 
is much more sensitive to metal supplementation and is “poisoned” by excess Zn, confirming 
that the native activity is more robust to fluctuations in metal content. Moreover, this 
preliminary finding of apparent extreme sensitivity to mutations near the Mn-binding site, 
which is particularly acute for the promiscuous activity, supports the notion that it is a crucial 
“catalytic hotspot” for the dipeptidase activity of the enzyme. A larger sampling of focused 
libraries may be required to assess whether it is much easier to identify mutations selectively 
affecting the promiscuous activity compared to the native, than the reverse. 
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Robustness of native activity to inhibition. 
 
Our previous results of DapE activity in vitro suggest that it is relatively easy to inhibit the 
promiscuous activity with competitive inhibitors designed to bind selectively to Mn, whereas 
the native activity with the same metallo-isoform is unaffected (see Chapter 6). For example, 
Dab-DAP inhibits the promiscuous activity, but not native activity in any metalloisoform, 
suggesting that the native substrate mode of binding is more robust to competition by 
inhibitors. Moreover, although Zn-selective inhibitors can be identified in vitro, such as L-
captopril (see Chapter 3), the function of the desuccinylase activity is unlikely to be affected, 
because the native activity is also catalysed by the Mn-isoform of DapE. Overall, these kinetic 
studies support that the native activity may be intrinsically or kinetically more robust, being a 
product of evolution. 
 
Our mechanistic model of substrate interactions with DapE suggests that the promiscuous 
activity mostly relies on the bidentate binding of the dipeptide to Mn (Figure 24), whereas the 
native substrate distributes its binding energy to the enzyme more widely. We postulate that 
such a localised and specific interaction of the promiscuous substrate with DapE contributes 
to the apparent fragility of the reaction to genetic disruption or inhibition, due to lack of 
redundant interactions. In conclusion, besides systemic effects in vivo, such as metal 
availability, requirement for products and protein expression levels, that appear to make the 
native activity much more robust than the promiscuous activity, it is likely that the native 
activity has an intrinsic kinetic robustness compared to the promiscuous activity that may be 
the product of evolution. 
 
 
Figure 24. Hypothesis for the mode of substrate binding and metal coordination for native and 
promiscuous activities (see Chapter 6). 
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Interesting variants identified. 
 
Variant 3A1 (G179S, L199P & D264N), loses native activity under weak promoter and 
promiscuous activity under strong promoter but maintains native activity under strong 
promoter, suggesting that the mutations of this variant are making the enzyme less stable than 
the wild type. All the three residues, G179S, L199P & D264N are found in the dimerization 
domain, G179S is in the close proximity of R177 which can have a potential interaction with 
the substrate and also G179 is very much conserved in DapE homologs, suggesting that it 
may have a role in loss of native activity, (Figure 24).  
 
We found that variant 3A5 (D44Y, G46V, F51L, A98V, T166S, L199P & E313D) lost the 
promiscuous activity even under the strong promoter, whilst maintaining the native activity 
both under strong and weak promoters, suggesting that the native activity has an intrinsic 
robustness such that it can withstand the mutational burden that is responsible for the total 
loss of promiscuous activity in vivo; however, the variant also withstands lower expression 
under selection for native activity. Consequently, it is most likely that mutations of this 
variant cause intrinsic loss of promiscuous over native activity. The mutations at positions 
D44Y, G46V and F51L are in the vicinity of the metal (Zn1) binding residue, H66. The 
mutation, A98V is adjacent to the bridging aspartate, D99, of the two metal ions (Zn1 & Zn2) 
and it is very well conserved in DapE-homologs. Residues T166S, L199P & E313D are in the 
dimerisation domain (Figure 25). 
 
Variant M4B3 (V233L, A307T & R332H), gains promiscuous activity under weak promoter 
and maintains promiscuous activity under strong promoter and also native activity under both 
promoters. Variant M4B3 appeared to gain promiscuous activity under the weak promoter in 
very stringent selection with IPTG, unlike wild type. Residue V233L is in the dimerisation 
domain and the residues A307T & R332H are in the catalytic domain; both are moderately 
conserved residues in DapE homologs; in addition R332 is in the positioned close to the 
substrate binding residue 334 (Figure 25). 
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In summary all these variants that lose promiscuous activity under strong promoter, (Figure 
25), apparently have more severe mutations, such as A98V, which is adjacent to the metal 
bridging residue D99 and mutations (P71L, A105T, D171N, V252M & T320M/K) that are 
close to the substrate binding residues. A most interesting mutation is N344Y, which is near 
the Mn-binding site. Besides the localization of these mutations around the catalytic site, it 
was also noted that these residues are in general well conserved in DapE homologs. It will be 
interested to explore whether these variants have improved/reduced native activity and/or 
promiscuous activity compared to wild type. 
 
 
 
 
Figure 25. Structure of the S.enterica DapE, homology model obtained from Swiss Protein Model.14  
Upper; left is variant-3A1 and right is variant-3A5. Bottom; left is variant-M4B3 and right is 
representative of different variants. Residues are showed in sticks, colouring of atoms; Carbon 
(yellow), Hydrogen (gray), Nitrogen (blue), Oxygen (red) & Sulfur (green). Zn1 (Blue) & Zn2 (Light 
blue), numbers 1 & 2 represents the position of the metal ion and the 2nd metal should be Mn for 
promiscuous activity. (*) residue from the opposite monomer. The images were created by using 
Pymol. 
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Discussion 
 
The randomized libraries of wild type DapE always have at least 3 times more survivors for 
the native activity compared to the promiscuous activity. We found that the lysine 
supplementation does not influence having more survivors for native activity over the 
promiscuous activity; however the lysine supplementation allowed increased survival under 
the weak promoter compared to no lysine supplementation. Our findings suggest that protein 
expression level can play a crucial role in the tolerance to mutational burden. If the templates 
used for the randomization were already pre-selected for one or the other activity, such pre-
selection did not appear to give any advantage for having more survivors for that particular 
activity. Presumably, evolution of specialization and potentially increased robustness for a 
particular activity under selection requires larger libraries and more rounds of selection than 
explored here. 
 
We conclude that the native desuccinylase activity of DapE is more robust than promiscuous 
dipeptidase activity, as determined by more survivors after random mutagenesis and selection; 
tolerance to lower protein expression levels; possibility of surviving a higher mutational 
burden and relative independence to metal availability. Consequently, the robustness of DapE 
native activity is largely a systemic property, dependent on a physiological environment that 
has been presumably highly-optimised by evolution.  
 
Our kinetic and mutational analyses also suggest that the DapE enzyme itself may be 
intrinsically more robust for the native activity, as assessed by a slightly higher kcat for the 
native substrate; by multiple isoforms maintaining native function in vitro; by the resistance 
of native function to competitive inhibition and the apparent inability to identify mutations 
that preferentially lose the native activity over the promiscuous activity. Besides all the 
systemic effects, the native activity thus appears also to exhibit intrinsic kinetic robustness 
compared to promiscuous activity. Importantly two independent sites (A98 and N344 I347 H348), 
around the active site, preferentially disrupted the promiscuous activity but not the native 
activity. Conversely no mutations were identified that disrupted the native activity 
preferentially. The kinetic characterization of the variants selected for native activity and for 
the promiscuous activity and especially the unbiased variants (i.e. variants selected just for 
ampicillin) that have one or the other activity may provide more insights about the intrinsic 
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robustness of the native or promiscuous activity. Exploration of kinetic parameters will be 
crucial to ensure that the increased or decreased kinetic efficiency of the enzyme activity is 
not just due to expression or changes in stability of the variant protein compared to the wild 
type (ΔΔG), i.e. improved catalysis may compensate for lowered stability or vise versa. 
 
Based on our conclusion that the native activity is more robust than the promiscuous activity, 
we postulate that the DapE native activity might have a much higher upper limit (excess 
fitness) compared to promiscuous activity. In this scenario, most or all the variants selected 
for native activity may have reduced fitness, but still be further from the minimum threshold / 
death line of the enzyme activity. In contrast, the fitness of the promiscuous enzyme may be 
much closer to the limits of disruption, i.e. the “death line” and hence almost any 
perturbations will affect survival (Figure 26). We propose that the native activity has “excess 
fitness” that effectively buffers the phenotypic effect of random disruption. In contrast, the 
promiscuous activity does not have such a buffering zone and is effectively working close to 
the survival threshold. The evolutionary consequence of the lack of tolerance to mutations is 
that the enzyme selected promiscuous activity is more likely to become extinct, i.e. a 
promiscuous function has a “fragile birth”. 
 
 
 
Figure 25. Model showing the relative fitness of native activity over promiscuous activity. ΔF is fitness 
and ΔΔF is relative fitness. 
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When selected for promiscuous activity as well as for “both activities” at the same time, one 
could expect that the native activity would lowered more than the promiscuous activity; 
however our results clearly indicated that the native activity is always maintained for all the 
variants selected for promiscuous activity, thereby suggesting that the native activity has more 
functional robustness compared to the promiscuous activity.  
 
Outlook 
 
Broader perspectives of planned research 
 
Molecular insights underpinning robustness are of fundamental importance for the 
advancement of science, but also useful for practical applications such as the design of 
pharmaceuticals and in synthetic biology.15 It is envisaged that the understanding of 
robustness at the molecular level will allow either the direct engineering of robustness in 
enzymes and networks, or alternatively allow to implement Darwinian protocols for the 
evolution of robustness from more primitive designs, in what may be called “systems-biology 
directed evolution”. 
 
Moreover, since robustness is a feature of many fields of human knowledge, including 
engineering, social sciences (e.g. economy) and information sciences,16 such insights have 
potential to be transferable beyond chemistry and biology.  
 
In summary, our neutral evolution experiments in the laboratory suggest that the native 
activity of DapE is more robust to random mutagenesis than its promiscuous activity. 
Moreover, our results support the notion that robustness is a systemic property, dependent on 
varied factors like metal availability and level of gene expression, as well as hinting at 
intrinsic genetic factors of enzyme mechanisms that contribute to robust catalysis. In 
conclusion, emerging promiscuous enzyme functions rely greatly upon its environment for its 
survival when taking their first tentative steps in evolution and toward increased robustness. 
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CHAPTER 8 
 
Outlook 
 
1. Our findings of the mechanism of native and promiscuous enzyme activities of DapE 
are illustrative enough for understanding the reaction mechanism. However a crystal 
structure of DapE of S.enterica with an inhibitor bound in the active to one of the 
metalloforms, especially for the Zn/Mn form of the enzyme may provide an additional 
and visual evidence for the bi-dentate binding of the promiscuous substrate.  
 
2. DapE is certainly a unique target for antibiotics as it is not found in humans. Much 
structural and functional information is known about DapE, especially compared to 
other enzymes of the lysine biosynthetic pathway. Lack of mechanistic insights of 
DapE has been a serious drawback for the design of potential inhibitors for DapE.1 
Our findings may provide impactful insights for the design of new classes of inhibitors 
targeting DapE. 
 
3. A surprising and little-understood finding in this thesis is that strong-binding and 
selective binders of the Mn isoform of DapE, which inhibit the promiscuous activity, 
fail to inhibit the native activity. Such functional-selective inhibition has potentially 
wide implications for control of metabolism and evolution, because the phenomenon 
adds a whole additional layer of complexity in enzyme regulation. It will be 
interesting to establish the role of endogenous inhibitors for regulation of enzyme 
activities in physiological settings. Moreover, detailed molecular insights on how the 
native substrate manages to outcompete a bound inhibitor (which the promiscuous 
substrate fails to do) may be of fundamental importance to understand enzyme 
mechanisms and selectivity. 
 
4. Apparently subtle differences in metal-coordination can lead to huge differences in 
catalytic outcome. For bacteria under selection for DapE activity, such small 
differences may be the difference between life and death. Considering that 
approximately one-third of structurally characterized proteins and approximately half 
of all proteins are thought to be metalloproteins,2-6 there is an urgent need to get 
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increased detailed understanding of kinetic properties of metals and of metal-ligand 
exchange during catalysis. Such atomic and molecular detail is at the forefront of 
enzyme chemistry and will require an interdisciplinary approach, including not just X-
ray crystallography (which has important limitations) but enzymology and 
computational chemistry. 
 
5. Kinetic characterization of the various mutants of the neutrally evolved DapE library 
would provide crucial data that can be used for the quantification of the functional 
robustness of the native and promiscuous activities. Apart from kinetic 
characterization, it may be possible to explore the ΔΔG of all these variants compared 
to the wild type using the bioinformatics tools (e.g. FOLDX), to correlate kinetic data 
in vivo with the thermodynamic data, ΔΔG.  
 
a. For example, we found one variant, M4B3, that could survive the stringent 
selection under weak promoter, it could be interesting to see the kinetic 
properties of this variant compared to the wild type; our prediction is that this 
neutrally-evolved variant may have kinetically increased promiscuous activity 
compared to the wild type. It may be of interest also to follow the process of 
specialisation toward the dipeptidase activity of this variant, to explore 
whether it correlates with increasing functional robustness for the evolving 
activity (and loss of functional robustness for the desuccinylase activity). 
 
b. Another example is variant 3A5, which loses only promiscuous activity and 
maintains the native activity even under weak promoter; the kinetic properties 
of this variant may provide evidence if the robustness of the native activity can 
be evolved further or not.  
 
6. We found that Mn supplementation can provide an additional advantage for the 
promiscuous enzyme activity, which can be implemented for the evolution of 
promiscuous activity under Mn supplemented selection medium, especially under the 
weak promoter. A similar strategy could be implemented for selection of other metal-
activities, for example for the reported weak dipeptidase activity of DapE with Cd.7 
The laboratory evolution for Cd-dependent hydrolase activity could reproduce natural 
evolution of a Cd-dependent carbonic anhydrase in marine diatoms.8  
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7. Since we conclude that the native activity is more robust than the promiscuous 
activity, does it mean that the native activity has already reached the limit of 
evolvability or can it be evolved further? A way forward to find the further 
evolvability of the native activity is to use the stringent selection conditions for the 
native activity, i.e. under weak promoter with IPTG and/or in presence of a 
competitive inhibitor. If the native activity is evolvable further, it suggests that 
evolution may not reach the maximum optimisation as it may not require such extreme 
efficiency for survival or may even be a counterproductive strategy for evolvability. 
  
8. The finding of robustness of native activity in case of DapE may not apply for all 
other promiscuous enzymes universally. In order to generalise this concept, it is 
important to explore robustness of native and promiscuous activity in other enzymes. 
Towards this direction, we have started working on another structurally similar 
enzyme, Sapep of S.aureus, which has a promiscuous beta-lactamase activity.9,10 
 
9. Another fundamental question that arises from our findings of robustness of native 
activity as a systemic property is whether such systemic robustness is evolvable. We 
have already initiated this project by evolving the bacterial strain under the selection 
pressure for native activity, promiscuous activity and for both activities at the same 
time, together with a control without any selection pressure for DapE activity. 
However, these bacterial strains need to be further validated for their systemic 
evolution. 
 
10. In 1967, Ohno proposed that gene duplication is an evolutionary approach that nature 
adapted for the creation of new enzyme activities.11 However, little effort effort has 
been made since then to prospectively test such a hypothesis in laboratory evolution 
experiments. In our studies we have identified some variants that show gene 
duplications and these variants could be a potential resource for evolving one activity 
or the other activity, in presence of gene duplicates. 
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